<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" dtd-version="1.3" xml:lang="en" article-type="research-article">
  <?properties open_access?>
  <processing-meta base-tagset="archiving" mathml-version="3.0" table-model="xhtml" tagset-family="jats">
    <restricted-by>pmc</restricted-by>
  </processing-meta>
  <front><journal-meta><journal-id journal-id-type="nlm-ta">Kidney360</journal-id><journal-id journal-id-type="iso-abbrev">Kidney360</journal-id><journal-id journal-id-type="coden">KIDNEY</journal-id><journal-id journal-id-type="publisher-id">Kidney360</journal-id><journal-title-group><journal-title>Kidney360</journal-title></journal-title-group><issn pub-type="epub">2641-7650</issn><publisher><publisher-name>American Society of Nephrology</publisher-name></publisher></journal-meta>
<article-meta><article-id pub-id-type="pmid">38689396</article-id><article-id pub-id-type="pmc">11371350</article-id>
<article-id pub-id-type="publisher-id">K360-2023-000788</article-id><article-id pub-id-type="doi">10.34067/KID.0000000000000461</article-id><article-id pub-id-type="art-access-id">00009</article-id><article-version vocab="JAV" vocab-identifier="http://www.niso.org/publications/rp/RP-8-2008.pdf" article-version-type="Version of Record">3</article-version><article-categories><subj-group subj-group-type="heading"><subject>Clinical Research</subject></subj-group><subj-group subj-group-type="heading"><subject>Cystic Kidney Disease</subject></subj-group></article-categories><title-group><article-title>Genetic Analysis of Severe Polycystic Liver Disease in Japan</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-4187-1067</contrib-id><name><surname>Mizuno</surname><given-names>Hiroki</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="http://credit.niso.org/contributor-roles/project-administration/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="http://credit.niso.org/contributor-roles/resources/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Software" vocab-term-identifier="http://credit.niso.org/contributor-roles/software/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="http://credit.niso.org/contributor-roles/validation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-8283-1507</contrib-id><name><surname>Besse</surname><given-names>Whitney</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Funding acquisition" vocab-term-identifier="http://credit.niso.org/contributor-roles/funding-acquisition/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Project administration" vocab-term-identifier="http://credit.niso.org/contributor-roles/project-administration/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Resources" vocab-term-identifier="http://credit.niso.org/contributor-roles/resources/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Software" vocab-term-identifier="http://credit.niso.org/contributor-roles/software/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="http://credit.niso.org/contributor-roles/validation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-7326-4988</contrib-id><name><surname>Sekine</surname><given-names>Akinari</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff3" ref-type="aff">
<sup>3</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Formal analysis" vocab-term-identifier="http://credit.niso.org/contributor-roles/formal-analysis/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0009-0008-2935-0430</contrib-id><name><surname>Long</surname><given-names>Kelly T.</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/"/></contrib><contrib contrib-type="author"><name><surname>Kurihara</surname><given-names>Shigekazu</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-1494-3291</contrib-id><name><surname>Oba</surname><given-names>Yuki</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-3264-9691</contrib-id><name><surname>Yamanouchi</surname><given-names>Masayuki</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Hasegawa</surname><given-names>Eiko</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-0825-2512</contrib-id><name><surname>Suwabe</surname><given-names>Tatsuya</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0003-2092-4094</contrib-id><name><surname>Sawa</surname><given-names>Naoki</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><name><surname>Ubara</surname><given-names>Yoshifumi</given-names></name><xref rid="aff1" ref-type="aff">
<sup>1</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-5062-4629</contrib-id><name><surname>Somlo</surname><given-names>Stefan</given-names></name><xref rid="aff4" ref-type="aff">
<sup>4</sup>
</xref><xref rid="aff5" ref-type="aff">
<sup>5</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="http://credit.niso.org/contributor-roles/supervision/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0002-0444-101X</contrib-id><name><surname>Hoshino</surname><given-names>Junichi</given-names></name><xref rid="aff2" ref-type="aff">
<sup>2</sup>
</xref><xref rid="aff6" ref-type="aff">
<sup>6</sup>
</xref><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Conceptualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/conceptualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Data curation" vocab-term-identifier="http://credit.niso.org/contributor-roles/data-curation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Investigation" vocab-term-identifier="http://credit.niso.org/contributor-roles/investigation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Methodology" vocab-term-identifier="http://credit.niso.org/contributor-roles/methodology/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Supervision" vocab-term-identifier="http://credit.niso.org/contributor-roles/supervision/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Validation" vocab-term-identifier="http://credit.niso.org/contributor-roles/validation/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Visualization" vocab-term-identifier="http://credit.niso.org/contributor-roles/visualization/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; original draft" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-original-draft/"/><role vocab="CRediT" vocab-identifier="http://credit.niso.org/" vocab-term="Writing &#x2013; review &amp; editing" vocab-term-identifier="http://credit.niso.org/contributor-roles/writing-review-editing/"/></contrib><aff id="aff1"><label>1</label>Nephrology Center Toranomon Hospital Kajigaya, Kawasaki, Japan</aff><aff id="aff2"><label>2</label>Nephrology Center Toranomon Hospital, Tokyo, Japan</aff><aff id="aff3"><label>3</label>Okinaka Memorial Institute for Medical Research, Tokyo, Japan</aff><aff id="aff4"><label>4</label>Section of Nephrology, Yale University School of Medicine, New Haven, Connecticut</aff><aff id="aff5"><label>5</label>Department of Genetics, Yale School of Medicine, New Haven, Connecticut</aff><aff id="aff6"><label>6</label>Department of Nephrology, Tokyo Women's Medical University, Tokyo, Japan</aff></contrib-group><author-notes><corresp><bold>Correspondence:</bold> Dr. Hiroki Mizuno or Dr. Whitney Besse, email: <email>hilomiz@yahoo.co.jp</email> or <email>whitney.besse@yale.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>8</month><year>2024</year></pub-date><pub-date pub-type="epub"><day>01</day><month>5</month><year>2024</year></pub-date><volume>5</volume><issue>8</issue><fpage>1106</fpage><lpage>1115</lpage><history><date date-type="received"><day>25</day><month>10</month><year>2023</year></date><date date-type="accepted"><day>25</day><month>4</month><year>2024</year></date></history><permissions><copyright-statement>Copyright &#xA9; 2024 The Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the American Society of Nephrology</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncndlicense">https://creativecommons.org/licenses/by-nc-nd/4.0/</ali:license_ref><license-p>This is an open access article distributed under the terms of the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND)</ext-link>, where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.</license-p></license></permissions><self-uri xlink:href="kidney360-5-1106.pdf"/><abstract abstract-type="graphical"><title>Visual Abstract</title><p><fig position="float" id="absf1" fig-type="featured"><graphic xlink:href="kidney360-5-1106-g001" position="float"/></fig>
</p></abstract><abstract><sec><title>Key Points</title><p>
<list list-type="bullet"><list-item><p>Among patients with severe polycystic liver disease (PLD) (height-adjusted total liver volume of &lt;1800 ml/m), <italic toggle="yes">PKD2</italic> variants were found in 34%.</p></list-item><list-item><p>Three patients with <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> variants are reported with severe PLD but normal-sized kidneys (hTKV of &lt; 250 ml/m).</p></list-item></list>
</p></sec><sec><title>Background</title><p>Polycystic liver disease (PLD) is present in most patients with autosomal dominant polycystic kidney disease (ADPKD). PLD can alternatively be found with few, if any, kidney cysts as a diagnosis of isolated PLD (autosomal dominant PLD [ADPLD]). Several genes are identified as causative for this spectrum of phenotypes; however, the relative incidence of genetic etiologies among patients with severe PLD is unknown.</p></sec><sec><title>Methods</title><p>Patients with ADPKD or ADPLD having severe PLD defined as height-adjusted total liver volume (hTLV) &gt;1800 ml/m were recruited. Subsequent clinical care was followed. Genetic analysis was performed using whole exome sequencing.</p></sec><sec><title>Results</title><p>We enrolled and sequenced 49 patients (38 women, 11 men). Pathogenic or suspected pathogenic variants in polycystic disease genes were found in 44 of 49 patients (90%). The disease gene was <italic toggle="yes">PKD1</italic> in 20 of 44 patients (45%), <italic toggle="yes">PKD2</italic> in 15 of 44 patients (34%), <italic toggle="yes">PRKCSH</italic> in 5 of 44 patients (11%), <italic toggle="yes">GANAB</italic> in 2 of 44 patients (5%), <italic toggle="yes">SEC63</italic> in 1 of 44 patients (2%), and <italic toggle="yes">ALG8</italic> in 1 of 44 patients (2%). The median hTLV was no different between genetically defined ADPKD and ADPLD groups (4431 [range, 1817&#x2013;9148] versus 3437 [range, 1860&#x2013;8211]) ml, <italic toggle="yes">P</italic> = 0.77), whereas height-adjusted kidney volume was larger as expected in ADPKD than in ADPLD (607 [range, 190&#x2013;2842] versus 179 [range, 138&#x2013;234] ml/m, <italic toggle="yes">P</italic> &lt; 0.01). Of the clinically defined ADPKD patients, 20 of 38 patients (53%) were <italic toggle="yes">PKD1</italic>, 15 of 38 (39%) were <italic toggle="yes">PKD2</italic>, and 3 (8%) remained genetically unsolved. Among patients with a pathogenic <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> variant, we found three patients with a liver-dominant ADPKD (severe PLD with height-adjusted total kidney volume &lt;250 ml/m).</p></sec><sec><title>Conclusions</title><p>ADPLD-related genes represent 20% of patients with severe PLD in our cohort. Of those enrolled with ADPKD, we observed a higher frequency of <italic toggle="yes">PKD2</italic> carriers than in any previously reported ADPKD cohorts. Although there was no significant difference in the hTLV between patients with <italic toggle="yes">PKD1</italic> and <italic toggle="yes">PKD2</italic> in this cohort, our data suggest that enrollment on the basis of severe PLD may enrich for patients with <italic toggle="yes">PKD2</italic>.</p></sec></abstract><kwd-group><kwd>ADPKD</kwd><kwd>cystic kidney</kwd><kwd>gene expression</kwd><kwd>polycystic kidney disease</kwd></kwd-group><funding-group><award-group id="award1"><funding-source xlink:href="https://doi.org/10.13039/100012832">Okinaka Memorial Institute for Medical Research</funding-source><principal-award-recipient>Hiroki Mizuno</principal-award-recipient></award-group></funding-group><funding-group><award-group id="sp1"><funding-source>Okinaka Memorial Institute for Medical Research<named-content content-type="funder-id">Hiroki Mizuno</named-content></funding-source></award-group></funding-group><counts><fig-count count="6"/><table-count count="2"/><ref-count count="54"/><page-count count="10"/></counts><custom-meta-group><custom-meta><meta-name>OPEN-ACCESS</meta-name><meta-value>TRUE</meta-value></custom-meta><custom-meta><meta-name>Read-along</meta-name><meta-value>YES</meta-value></custom-meta></custom-meta-group></article-meta></front>
  <body>
    <sec id="s2">
      <title>Introduction</title>
      <p>Polycystic liver disease (PLD) is a clinical term used to describe the phenotype of multiple simple fluid-filled cysts in the liver.<sup><xref rid="B1" ref-type="bibr">1</xref></sup> PLD can occur as an extrarenal manifestation of autosomal dominant polycystic kidney disease (ADPKD) or without meaningful kidney cyst burden known as isolated autosomal dominant PLD (ADPLD, also abbreviated PCLD). The prevalence of ADPKD is approximately 1:1000, while 94% of patients with ADPKD over age 35 years have liver cysts, and the severity and clinical relevance of the liver cysts are highly variable.<sup><xref rid="B2" ref-type="bibr">2</xref>,<xref rid="B3" ref-type="bibr">3</xref></sup> Clinically identified ADPLD has an estimated prevalence of 1:10,000&#x2013;158,000, but mild cases may often be clinically undiagnosed.<sup><xref rid="B4" ref-type="bibr">4</xref><xref rid="B5" ref-type="bibr"/>&#x2013;<xref rid="B6" ref-type="bibr">6</xref></sup> Patients with symptomatic PLD are often women for reasons attributed to hormonal effects.<sup><xref rid="B7" ref-type="bibr">7</xref></sup></p>
      <p>ADPKD and ADPLD are genetic disorders with related mechanisms. ADPKD is caused by heterozygous genetic variants in the <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> genes, which encode the polycystin proteins. <italic toggle="yes">PKD1</italic> accounts for approximately 77% of genetically defined patients.<sup><xref rid="B8" ref-type="bibr">8</xref>,<xref rid="B9" ref-type="bibr">9</xref></sup> ADPLD is caused by heterozygous genetic variants in any of several disease genes: <italic toggle="yes">PRKCSH</italic>,<sup><xref rid="B10" ref-type="bibr">10</xref></sup>
<italic toggle="yes">SEC63</italic>,<sup><xref rid="B11" ref-type="bibr">11</xref></sup>
<italic toggle="yes">ALG8</italic>,<sup><xref rid="B1" ref-type="bibr">1</xref></sup>
<italic toggle="yes">SEC61B</italic>,<sup><xref rid="B12" ref-type="bibr">12</xref></sup>
<italic toggle="yes">ALG9</italic>,<sup><xref rid="B13" ref-type="bibr">13</xref></sup> or <italic toggle="yes">GANAB</italic>.<sup><xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B14" ref-type="bibr">14</xref></sup>
<italic toggle="yes">PRKCSH</italic> and <italic toggle="yes">SEC63</italic> appear to be the most commonly seen disease genes for ADPLD.<sup><xref rid="B4" ref-type="bibr">4</xref></sup> In many cases, <italic toggle="yes">GANAB</italic>, <italic toggle="yes">ALG8</italic>, and <italic toggle="yes">ALG9</italic> have kidney cysts instead of, or in addition to, liver cysts<sup><xref rid="B1" ref-type="bibr">1</xref></sup> and may be found to explain patients clinically characterized as mild or atypical ADPKD. These ADPLD-related genes encode the proteins in the endoplasmic reticulum, and the loss of function of these genes causes the reduction of the functional polycystin-1 (PC1) in the kidney and liver, which plays a crucial role in cystogenesis.<sup><xref rid="B12" ref-type="bibr">12</xref>,<xref rid="B15" ref-type="bibr">15</xref>,<xref rid="B16" ref-type="bibr">16</xref></sup></p>
      <p>Clinical studies have been conducted to elucidate the clinical course of PLD<sup><xref rid="B17" ref-type="bibr">17</xref><xref rid="B18" ref-type="bibr"/><xref rid="B19" ref-type="bibr"/><xref rid="B20" ref-type="bibr"/><xref rid="B21" ref-type="bibr"/>&#x2013;<xref rid="B22" ref-type="bibr">22</xref></sup>; however, gene-based comparisons were not performed in these studies to our knowledge. However, given the more recent realization that several genes&#x2014;particularly <italic toggle="yes">GANAB</italic> and <italic toggle="yes">ALG8</italic>&#x2014;can manifest with kidney cysts in addition to liver cysts, the underlying genetics in these patients may make relevant distinctions. In contrast to ADPKD kidney cyst severity, ADPKD liver cyst severity appears not to be affected by genotype (<italic toggle="yes">PKD1</italic> truncating, <italic toggle="yes">PKD1</italic> nontruncating, or <italic toggle="yes">PKD2</italic>).<sup><xref rid="B18" ref-type="bibr">18</xref>,<xref rid="B23" ref-type="bibr">23</xref><xref rid="B24" ref-type="bibr"/>&#x2013;<xref rid="B25" ref-type="bibr">25</xref></sup> To characterize and learn from the genotypes capable of and likely to produce severe PLD, we set up a cohort study of patients with ADPKD and ADPLD who have severe PLD defined as a height-adjusted total liver volume (hTLV) &gt;1800 ml/m to conduct genetic analysis and genotype&#x2013;phenotype correlations. We predefined this threshold based on its use in the literature and data suggesting that near or above this liver size clinical symptoms are seen in the majority of patients.<sup><xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B26" ref-type="bibr">26</xref></sup></p>
    </sec>
    <sec sec-type="methods" id="s3">
      <title>Method</title>
      <sec>
        <title>Study Population</title>
        <p>Electronic medical records were reviewed for patients with polycystic liver or polycystic kidney who regularly visited from September 2018 to April 2019 in the nephrology department of Toranomon Hospital or Toranomon Hospital Kajigaya. The inclusion criteria of this cohort were patients over 20 years who had computed tomography (CT) or magnetic resonance imaging showing severe polycystic liver (hTLV &gt;1800 ml/m) with or without polycystic kidneys&#x2014;defined as having &gt;10 cysts in two kidneys&#x2014;and who were seen in clinic and able to consent. Study participation was offered to all patients meeting these criteria for whom a family member was not already enrolled, and 49 participants chose to enroll and completed sample collection and written informed consent. This study was approved by the institutional review board in Toranomon Hospital and Toranomon Hospital Kajigaya (2018-1), and adhered to the Declaration of Helsinki.</p>
      </sec>
      <sec>
        <title>Genetic Evaluation</title>
        <p>DNA samples were extracted at Toranomon Hospital. Whole exome sequencing (WES) was performed at the Yale Center for Genome Analysis and analyzed by authors using validated pipelines previously described.<sup><xref rid="B12" ref-type="bibr">12</xref></sup> Only rare variants with a minor allele frequency of &lt;1&#xD7;10<sup>&#x2212;4</sup> in the gnomAD database were considered.<sup><xref rid="B27" ref-type="bibr">27</xref>,<xref rid="B28" ref-type="bibr">28</xref></sup> Nontruncating variants were adjudicated using American College of Medical Genetics criteria.<sup><xref rid="B29" ref-type="bibr">29</xref></sup> Those patients with <italic toggle="yes">PKD1</italic> variant of unknown significance (VUS) were characterized as <italic toggle="yes">PKD1</italic> patients if the VUS met at least two of the following four criteria&#x2014;novel in gnomAD,<sup><xref rid="B27" ref-type="bibr">27</xref></sup> CADD score &gt;20,<sup><xref rid="B30" ref-type="bibr">30</xref></sup> deleterious by metaSVM,<sup><xref rid="B31" ref-type="bibr">31</xref></sup> and REVEL &gt;0.7.<sup><xref rid="B32" ref-type="bibr">32</xref></sup> Calling of copy number variation is limited in research-grade WES. Nonetheless, large heterozygous deletions were implicated if two criteria were met: (<italic toggle="yes">1</italic>) there was a statistically significant reduction (approximately 50%) in read depth throughout one large exon or more than one contiguous exon in comparison with the same exon in samples sequenced in parallel (same flow cell or batch) and (<italic toggle="yes">2</italic>) the implicated heterozygous deletion region was devoid of heterozygous variants. Implicated heterozygous deletions were confirmed using genomic quantitative PCR. For each region of interest, the relative allele count for the DNA sample from the patient with the suspected large deletion and that of three controls was evaluated in triplicate. Each sample's average cycle threshold for amplification of genomic regions within the implicated deletion was normalized to the same genomic DNA sample's amplification of an intronic region of <italic toggle="yes">GAPDH</italic>. Case fold difference was compared with the mean fold difference of the three controls to determine the relative allele count. If the mean relative allele count of technical triplicates was &#x2264;50%, the heterozygous deletion was considered confirmed.</p>
      </sec>
      <sec>
        <title>Clinical and Radiological Evaluation</title>
        <p>All clinical data were retrieved from the electronic medical records. Baseline demographics, laboratory data, and imaging data were collected on the day when the patients wrote informed consent; however, in case they had already experienced surgical interventions, including partial hepatectomy, percutaneous liver cyst aspiration, or transarterial embolization to liver arteries,<sup><xref rid="B33" ref-type="bibr">33</xref></sup> their most recent data before interventions were collected. The eGFR was calculated by the revised equation for Japanese people.<sup><xref rid="B34" ref-type="bibr">34</xref></sup> TLV and total kidney volume were calculated by a semiautomated program (Synapse Vincent, Fujifilm Medical) by CT scan and evaluated for hTLV and height-adjusted total kidney volume (hTKV). The predicted liver growth rate based on baseline imaging findings was calculated using the following equation,<sup><xref rid="B18" ref-type="bibr">18</xref></sup> and the baseline liver volume was postulated using the formula that calculated the standard liver volume for liver transplantation at the age of 18 years<sup><xref rid="B35" ref-type="bibr">35</xref></sup>:<disp-formula><mml:math id="m1" overflow="scroll"><mml:mrow><mml:mo>(</mml:mo><mml:mrow><mml:msup><mml:mrow><mml:mrow><mml:mo>(</mml:mo><mml:mfrac><mml:mrow><mml:mi>h</mml:mi><mml:mi>T</mml:mi><mml:mi>L</mml:mi><mml:mi>V</mml:mi></mml:mrow><mml:mn>645</mml:mn></mml:mfrac><mml:mo>)</mml:mo></mml:mrow></mml:mrow><mml:mfrac><mml:mn>1</mml:mn><mml:mrow><mml:mi>A</mml:mi><mml:mi>g</mml:mi><mml:mi>e</mml:mi><mml:mo>&#x2212;</mml:mo><mml:mn>18</mml:mn></mml:mrow></mml:mfrac></mml:msup><mml:mo>&#x2212;</mml:mo><mml:mn>1</mml:mn><mml:mo>)</mml:mo></mml:mrow><mml:mo>&#xD7;</mml:mo><mml:mn>100</mml:mn></mml:mrow></mml:math></disp-formula></p>
        <p>Moreover, serial hTLVs from multiple imaging studies were collected if available as part of routine clinical care before PLD-related interventions, and patients were classified based on the imaging classification.<sup><xref rid="B18" ref-type="bibr">18</xref></sup> Clinical data were collected blinded to genetic assessment.</p>
      </sec>
      <sec>
        <title>Statistical Analysis</title>
        <p>Categorical data were described as number and percent and analyzed by a two-tailed Fisher's exact test as appropriate, whereas continuous variables were described as the median and range and were analyzed by the Wilcoxon rank-sum test. Any <italic toggle="yes">P</italic> values below 0.05 were considered statistically significant. All statistical analyses were conducted by R statistical version 4.2.3 (R Foundation for Statistical Computing, Vienna, Austria, <ext-link xlink:href="http://R-project.org/" ext-link-type="uri">http://R-project.org/</ext-link>).</p>
      </sec>
    </sec>
    <sec sec-type="results" id="s4">
      <title>Results</title>
      <sec>
        <title>Baseline Characteristics of PLD Cohort</title>
        <p>We identified 701 charts of patients with ADPKD or ADPLD in our center for which the necessary imaging was available. We enrolled 49 patients of 49 families from among the 141 patients with severe PLD (hTLV &gt;1800 ml/m) in our center (Figure <xref rid="fig1" ref-type="fig">1</xref>). Among the 49 patients, 38 had a clinical diagnosis of ADPKD and 11 had a diagnosis of ADPLD (Table <xref rid="t1" ref-type="table">1</xref>). The median age was 57 years (range, 36&#x2013;76), and 38 patients (78%) were female. The median hTLV and hTKV were 4330 (range, 1817&#x2013;9148) ml/m and 415 (range, 57&#x2013;2842) ml/m, respectively. Surgical interventions were conducted in 39 patients (89%) (<ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 1</ext-link>). No patients underwent liver transplantation.</p>
        <fig position="float" id="fig1" fig-type="figure">
          <label>Figure 1</label>
          <caption>
            <p><bold>Toranomon hospital polycystic kidney and liver population and patient enrollment flowchart.</bold> All patients with severe PLD (hTLV &gt;1800 ml/m) who visited our clinic with the indicated patient phenotype subsets were offered enrollment, and the subset indicated in green text consented and were thus enrolled to participate. Enrollment and clinical indication of ADPKD versus ADPLD were carried out before genetic testing. ADPKD, autosomal dominant polycystic kidney disease; ADPLD, autosomal dominant polycystic liver disease; hTLV, height-adjusted total liver volume; PKD, polycystic kidney disease; PLD, polycystic liver disease.</p>
          </caption>
          <graphic xlink:href="kidney360-5-1106-g002" position="float"/>
        </fig>
        <table-wrap position="float" id="t1">
          <label>Table 1</label>
          <caption>
            <p>Clinical and genetic data of severe polycystic liver disease cohort</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1">No</th>
                <th align="center" rowspan="1" colspan="1">Sex</th>
                <th align="center" rowspan="1" colspan="1">Age at Diagnosis, yr</th>
                <th align="center" rowspan="1" colspan="1">Family History</th>
                <th align="center" rowspan="1" colspan="1">Age, yr</th>
                <th align="center" rowspan="1" colspan="1">hTKV, ml/m</th>
                <th align="center" rowspan="1" colspan="1">hTLV, ml/m</th>
                <th align="center" rowspan="1" colspan="1">Clinical Diagnosis</th>
                <th align="center" rowspan="1" colspan="1">Gene</th>
                <th align="center" rowspan="1" colspan="1">Variant</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">1</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">29</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">36</td>
                <td align="char" char="." rowspan="1" colspan="1">331</td>
                <td align="char" char="." rowspan="1" colspan="1">6510</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Trp4012X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">2</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">36</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">50</td>
                <td align="char" char="." rowspan="1" colspan="1">360</td>
                <td align="char" char="." rowspan="1" colspan="1">2974</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Ala1315Pro (VUS)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">3</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">41</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">59</td>
                <td align="char" char="." rowspan="1" colspan="1">572</td>
                <td align="char" char="." rowspan="1" colspan="1">4825</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Leu727Pro (LP)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">4</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">40</td>
                <td rowspan="1" colspan="1">Unk.</td>
                <td align="char" char="." rowspan="1" colspan="1">76</td>
                <td align="char" char="." rowspan="1" colspan="1">691</td>
                <td align="char" char="." rowspan="1" colspan="1">9148</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg799Pro (VUS)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">5</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">38</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">60</td>
                <td align="char" char="." rowspan="1" colspan="1">2842</td>
                <td align="char" char="." rowspan="1" colspan="1">6050</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Thr3135Met (LP)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">6</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">44</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">53</td>
                <td align="char" char="." rowspan="1" colspan="1">2414</td>
                <td align="char" char="." rowspan="1" colspan="1">6079</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Gln2243X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">7</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">51</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">61</td>
                <td align="char" char="." rowspan="1" colspan="1">1103</td>
                <td align="char" char="." rowspan="1" colspan="1">2198</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Val878Profs&#xD7;22</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">8</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">30</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">51</td>
                <td align="char" char="." rowspan="1" colspan="1">586</td>
                <td align="char" char="." rowspan="1" colspan="1">5763</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">c.11017-10C&gt;A</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">9</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">41</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">56</td>
                <td align="char" char="." rowspan="1" colspan="1">846</td>
                <td align="char" char="." rowspan="1" colspan="1">7043</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Gln1068X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">10</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">44</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">54</td>
                <td align="char" char="." rowspan="1" colspan="1">618</td>
                <td align="char" char="." rowspan="1" colspan="1">5347</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg4150Alafs&#xD7;48</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">11</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">46</td>
                <td rowspan="1" colspan="1">Unk.</td>
                <td align="char" char="." rowspan="1" colspan="1">63</td>
                <td align="char" char="." rowspan="1" colspan="1">2255</td>
                <td align="char" char="." rowspan="1" colspan="1">8518</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Gln1116X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">12</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">40</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">68</td>
                <td align="char" char="." rowspan="1" colspan="1">1098</td>
                <td align="char" char="." rowspan="1" colspan="1">6166</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Gln227X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">13</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">29</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">46</td>
                <td align="char" char="." rowspan="1" colspan="1">415</td>
                <td align="char" char="." rowspan="1" colspan="1">3389</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Ile985_Val991del</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">14</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">55</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">76</td>
                <td align="char" char="." rowspan="1" colspan="1">1065</td>
                <td align="char" char="." rowspan="1" colspan="1">3112</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Asn1269Leufs&#xD7;31</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">15</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">36</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">43</td>
                <td align="char" char="." rowspan="1" colspan="1">816</td>
                <td align="char" char="." rowspan="1" colspan="1">4759</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg2163X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">16</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">40</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">62</td>
                <td align="char" char="." rowspan="1" colspan="1">607</td>
                <td align="char" char="." rowspan="1" colspan="1">5996</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Phe2133del (LP)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">17</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">41</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">46</td>
                <td align="char" char="." rowspan="1" colspan="1">1102</td>
                <td align="char" char="." rowspan="1" colspan="1">3910</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Ser1915X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">18</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">46</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">59</td>
                <td align="char" char="." rowspan="1" colspan="1">190</td>
                <td align="char" char="." rowspan="1" colspan="1">2209</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Tyr1441Cys (VUS)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">19</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">44</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">50</td>
                <td align="char" char="." rowspan="1" colspan="1">435</td>
                <td align="char" char="." rowspan="1" colspan="1">3055</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Thr3049Ile (VUS)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">20</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">47</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">68</td>
                <td align="char" char="." rowspan="1" colspan="1">690</td>
                <td align="char" char="." rowspan="1" colspan="1">1912</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD1</italic>
</td>
                <td rowspan="1" colspan="1">p.Trp4012X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">21</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">42</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">57</td>
                <td align="char" char="." rowspan="1" colspan="1">930</td>
                <td align="char" char="." rowspan="1" colspan="1">3714</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg872X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">22</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">34</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">43</td>
                <td align="char" char="." rowspan="1" colspan="1">386</td>
                <td align="char" char="." rowspan="1" colspan="1">4162</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Gly143Alafs&#xD7;90</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">23</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">52</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">66</td>
                <td align="char" char="." rowspan="1" colspan="1">1194</td>
                <td align="char" char="." rowspan="1" colspan="1">4553</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg322Gln (P)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">24</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">49</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">49</td>
                <td align="char" char="." rowspan="1" colspan="1">202</td>
                <td align="char" char="." rowspan="1" colspan="1">1817</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg803X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">25</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">29</td>
                <td rowspan="1" colspan="1">No</td>
                <td align="char" char="." rowspan="1" colspan="1">42</td>
                <td align="char" char="." rowspan="1" colspan="1">913</td>
                <td align="char" char="." rowspan="1" colspan="1">4431</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">c.1549-1 G&gt;GCTGT</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">26</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">35</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">45</td>
                <td align="char" char="." rowspan="1" colspan="1">294</td>
                <td align="char" char="." rowspan="1" colspan="1">4700</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Asp339Valfs&#xD7;36</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">27</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">45</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">51</td>
                <td align="char" char="." rowspan="1" colspan="1">315</td>
                <td align="char" char="." rowspan="1" colspan="1">6051</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg654X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">28</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">40</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">53</td>
                <td align="char" char="." rowspan="1" colspan="1">257</td>
                <td align="char" char="." rowspan="1" colspan="1">3185</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg306X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">29</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">30</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">50</td>
                <td align="char" char="." rowspan="1" colspan="1">678</td>
                <td align="char" char="." rowspan="1" colspan="1">3702</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Cys509X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">30</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">61</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">62</td>
                <td align="char" char="." rowspan="1" colspan="1">657</td>
                <td align="char" char="." rowspan="1" colspan="1">5360</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Trp293X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">31</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">58</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">60</td>
                <td align="char" char="." rowspan="1" colspan="1">595</td>
                <td align="char" char="." rowspan="1" colspan="1">4330</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg322Gln (P)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">32</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">41</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">61</td>
                <td align="char" char="." rowspan="1" colspan="1">332</td>
                <td align="char" char="." rowspan="1" colspan="1">2611</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Tyr247X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">33</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">34</td>
                <td rowspan="1" colspan="1">No</td>
                <td align="char" char="." rowspan="1" colspan="1">38</td>
                <td align="char" char="." rowspan="1" colspan="1">284</td>
                <td align="char" char="." rowspan="1" colspan="1">5169</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg872X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">34</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">41</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">57</td>
                <td align="char" char="." rowspan="1" colspan="1">282</td>
                <td align="char" char="." rowspan="1" colspan="1">3333</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Gly143Alafs&#xD7;90</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">35</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">37</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">50</td>
                <td align="char" char="." rowspan="1" colspan="1">210</td>
                <td align="char" char="." rowspan="1" colspan="1">2936</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PKD2</italic>
</td>
                <td rowspan="1" colspan="1">p.Arg592X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">36</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">51</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">57</td>
                <td align="char" char="." rowspan="1" colspan="1">234</td>
                <td align="char" char="." rowspan="1" colspan="1">3437</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">GANAB</italic>
</td>
                <td rowspan="1" colspan="1">p.Thr851Pro (NM_198334) (VUS)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">37</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">50</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">61</td>
                <td align="char" char="." rowspan="1" colspan="1">162</td>
                <td align="char" char="." rowspan="1" colspan="1">6318</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">GANAB</italic>
</td>
                <td rowspan="1" colspan="1">p.Thr851Pro (NM_198334) (VUS)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">38</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">45</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">62</td>
                <td align="char" char="." rowspan="1" colspan="1">170</td>
                <td align="char" char="." rowspan="1" colspan="1">7454</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PRKCSH</italic>
</td>
                <td rowspan="1" colspan="1">Exon 1 and 2 del.</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">39</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">51</td>
                <td rowspan="1" colspan="1">No</td>
                <td align="char" char="." rowspan="1" colspan="1">55</td>
                <td align="char" char="." rowspan="1" colspan="1">198</td>
                <td align="char" char="." rowspan="1" colspan="1">3162</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PRKCSH</italic>
</td>
                <td rowspan="1" colspan="1">p.Glu125Valfs&#xD7;21</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">40</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">44</td>
                <td rowspan="1" colspan="1">Unk.</td>
                <td align="char" char="." rowspan="1" colspan="1">51</td>
                <td align="char" char="." rowspan="1" colspan="1">179</td>
                <td align="char" char="." rowspan="1" colspan="1">1960</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PRKCSH</italic>
</td>
                <td rowspan="1" colspan="1">c.1431+1G&gt;A</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">41</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">60</td>
                <td rowspan="1" colspan="1">No</td>
                <td align="char" char="." rowspan="1" colspan="1">71</td>
                <td align="char" char="." rowspan="1" colspan="1">208</td>
                <td align="char" char="." rowspan="1" colspan="1">8211</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PRKCSH</italic>
</td>
                <td rowspan="1" colspan="1">p.Glu125Valfs&#xD7;21</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">42</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">Young</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">72</td>
                <td align="char" char="." rowspan="1" colspan="1">138</td>
                <td align="char" char="." rowspan="1" colspan="1">2394</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">PRKCSH</italic>
</td>
                <td rowspan="1" colspan="1">p.Tyr423X</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">43</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">50</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">57</td>
                <td align="char" char="." rowspan="1" colspan="1">166</td>
                <td align="char" char="." rowspan="1" colspan="1">3387</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">SEC63</italic>
</td>
                <td rowspan="1" colspan="1">p.Thr469Leufs&#xD7;7</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">44</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">45</td>
                <td rowspan="1" colspan="1">Unk.</td>
                <td align="char" char="." rowspan="1" colspan="1">48</td>
                <td align="char" char="." rowspan="1" colspan="1">225</td>
                <td align="char" char="." rowspan="1" colspan="1">3527</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">
<italic toggle="yes">ALG8</italic>
</td>
                <td rowspan="1" colspan="1">Exon 1 deletion</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">45</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">37</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">38</td>
                <td align="char" char="." rowspan="1" colspan="1">280</td>
                <td align="char" char="." rowspan="1" colspan="1">6377</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">Unsolved</td>
                <td rowspan="1" colspan="1">n/a</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">46</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">40s</td>
                <td rowspan="1" colspan="1">Yes</td>
                <td align="char" char="." rowspan="1" colspan="1">71</td>
                <td align="char" char="." rowspan="1" colspan="1">995</td>
                <td align="char" char="." rowspan="1" colspan="1">6020</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">Unsolved</td>
                <td rowspan="1" colspan="1">n/a</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">47</td>
                <td rowspan="1" colspan="1">F</td>
                <td rowspan="1" colspan="1">66</td>
                <td rowspan="1" colspan="1">Unk.</td>
                <td align="char" char="." rowspan="1" colspan="1">67</td>
                <td align="char" char="." rowspan="1" colspan="1">162</td>
                <td align="char" char="." rowspan="1" colspan="1">2321</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">Unsolved</td>
                <td rowspan="1" colspan="1">n/a</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">48</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">38</td>
                <td rowspan="1" colspan="1">Unk.</td>
                <td align="char" char="." rowspan="1" colspan="1">49</td>
                <td align="char" char="." rowspan="1" colspan="1">967</td>
                <td align="char" char="." rowspan="1" colspan="1">6544</td>
                <td rowspan="1" colspan="1">ADPKD</td>
                <td rowspan="1" colspan="1">Unsolved</td>
                <td rowspan="1" colspan="1">n/a</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">49</td>
                <td rowspan="1" colspan="1">M</td>
                <td rowspan="1" colspan="1">Unknown</td>
                <td rowspan="1" colspan="1">No</td>
                <td align="char" char="." rowspan="1" colspan="1">75</td>
                <td align="char" char="." rowspan="1" colspan="1">57</td>
                <td align="char" char="." rowspan="1" colspan="1">3251</td>
                <td rowspan="1" colspan="1">ADPLD</td>
                <td rowspan="1" colspan="1">Unsolved</td>
                <td rowspan="1" colspan="1">n/a</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn fn-type="other">
              <p>ADPKD, autosomal dominant polycystic kidney disease; ADPLD, autosomal dominant polycystic liver disease; hTKV, height-adjusted total kidney volume; hTLV, height-adjusted total liver volume; LP, likely pathogenic; n/a, not available; P, pathogenic; PKD, polycystic kidney disease; PLD, polycystic liver disease; VUS, variant of unknown significance.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
      </sec>
      <sec>
        <title>Genetic Analysis</title>
        <p>We carried out WES on a research basis for all members in the enrolled cohort. Genetic findings are shown in Figure <xref rid="fig2" ref-type="fig">2</xref> and Table <xref rid="t1" ref-type="table">1</xref>. We found pathogenic or suspected pathogenic variants in 44 of 49 patients (90%). The disease gene was <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> in 35 of 44 (80%) patients, whereas other ADPLD-related genes were found in 9 of 44 (20%) patients. Of those with <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> variants, an unusually high percentage of 15 of 35 (43%) patients contained their pathogenic variant in <italic toggle="yes">PKD2</italic> (Tables <xref rid="t1" ref-type="table">1</xref> and <xref rid="t2" ref-type="table">2</xref>). Of the <italic toggle="yes">PKD1</italic> variants, 11 of 20 were truncating, and all 20 were unique from each other (Table <xref rid="t1" ref-type="table">1</xref>). Of the <italic toggle="yes">PKD2</italic> variants, 13 of 15 were truncating. There were two patients with the <italic toggle="yes">PKD2</italic> p.Arg872X, two with PKD2 p.Arg322Gln, and two with <italic toggle="yes">PKD2</italic> p.Gly143Alafs. We used the relatedness2 tool from vcftools<sup><xref rid="B36" ref-type="bibr">36</xref></sup> to ensure that no close familiar relationships were present in the cohort. No close (less than or equal to third degree) familial relationship was noted between these <italic toggle="yes">PKD2</italic> patients, but one relationship was found between the two <italic toggle="yes">GANAB</italic> patients. Only one patient had the <italic toggle="yes">PKD2</italic> p.Arg803X variant reported to be a founder mutation in a Taiwanese population.<sup><xref rid="B37" ref-type="bibr">37</xref></sup> One of the <italic toggle="yes">PKD2</italic> patients (patient 23) had both the <italic toggle="yes">PKD2</italic> p.Arg322Gln variant (&#x201C;highly likely pathogenic&#x201D; with multiple references in <ext-link xlink:href="https://pkdb.mayo.edu/variants" ext-link-type="uri">https://pkdb.mayo.edu/variants</ext-link>) and a rare VUS in <italic toggle="yes">PKD1</italic>, p.Gln2376Arg.</p>
        <fig position="float" id="fig2" fig-type="figure">
          <label>Figure 2</label>
          <caption>
            <p>
Disease gene for patients with severe PLD (height-adjusted total liver &gt;1800 ml/m) in this study.
</p>
          </caption>
          <graphic xlink:href="kidney360-5-1106-g003" position="float"/>
        </fig>
        <table-wrap position="float" id="t2">
          <label>Table 2</label>
          <caption>
            <p>The relative incidence of <italic toggle="yes">PKD1/PKD2</italic> variant carriers in published large cohorts of autosomal dominant polycystic kidney disease</p>
          </caption>
          <table frame="hsides" rules="groups">
            <thead>
              <tr>
                <th rowspan="1" colspan="1">Reference</th>
                <th align="center" rowspan="1" colspan="1">45</th>
                <th align="center" rowspan="1" colspan="1">46</th>
                <th align="center" rowspan="1" colspan="1">47</th>
                <th align="center" rowspan="1" colspan="1">48</th>
                <th align="center" rowspan="1" colspan="1">25</th>
                <th align="center" rowspan="1" colspan="1">49</th>
                <th align="center" rowspan="1" colspan="1">50</th>
                <th align="center" rowspan="1" colspan="1">51</th>
                <th align="center" rowspan="1" colspan="1">52</th>
                <th align="center" rowspan="1" colspan="1">53</th>
                <th align="center" rowspan="1" colspan="1">This Study</th>
                <th align="center" rowspan="1" colspan="1">This Study ADPKD Subset</th>
              </tr>
            </thead>
            <tbody>
              <tr>
                <td rowspan="1" colspan="1">Year</td>
                <td rowspan="1" colspan="1">2006</td>
                <td rowspan="1" colspan="1">2009</td>
                <td rowspan="1" colspan="1">2014</td>
                <td rowspan="1" colspan="1">2016</td>
                <td rowspan="1" colspan="1">2016</td>
                <td rowspan="1" colspan="1">2018</td>
                <td rowspan="1" colspan="1">2022</td>
                <td rowspan="1" colspan="1">2022</td>
                <td rowspan="1" colspan="1">2022</td>
                <td rowspan="1" colspan="1">2023</td>
                <td rowspan="1" colspan="1">2023</td>
                <td rowspan="1" colspan="1">2023</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Country</td>
                <td rowspan="1" colspan="1">United States</td>
                <td rowspan="1" colspan="1">Canada</td>
                <td rowspan="1" colspan="1">United States</td>
                <td rowspan="1" colspan="1">France</td>
                <td rowspan="1" colspan="1">United States</td>
                <td rowspan="1" colspan="1">United States</td>
                <td rowspan="1" colspan="1">Korea</td>
                <td rowspan="1" colspan="1">Japan</td>
                <td rowspan="1" colspan="1">Japan</td>
                <td rowspan="1" colspan="1">Japan</td>
                <td rowspan="1" colspan="1">Japan</td>
                <td rowspan="1" colspan="1">Japan</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Number of samples, <italic toggle="yes">n</italic></td>
                <td rowspan="1" colspan="1">241</td>
                <td rowspan="1" colspan="1">484</td>
                <td rowspan="1" colspan="1">447</td>
                <td rowspan="1" colspan="1">913</td>
                <td rowspan="1" colspan="1">434</td>
                <td rowspan="1" colspan="1">770</td>
                <td rowspan="1" colspan="1">162</td>
                <td rowspan="1" colspan="1">118</td>
                <td rowspan="1" colspan="1">129</td>
                <td rowspan="1" colspan="1">436</td>
                <td rowspan="1" colspan="1">49</td>
                <td rowspan="1" colspan="1">38</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"><italic toggle="yes">PKD1</italic>, <italic toggle="yes">n</italic> (%)</td>
                <td rowspan="1" colspan="1">153 (64)</td>
                <td rowspan="1" colspan="1">367 (76)</td>
                <td rowspan="1" colspan="1">362 (81)</td>
                <td rowspan="1" colspan="1">678 (74)</td>
                <td rowspan="1" colspan="1">362 (83)</td>
                <td rowspan="1" colspan="1">656 (85)</td>
                <td rowspan="1" colspan="1">116 (72)</td>
                <td rowspan="1" colspan="1">90 (76)</td>
                <td rowspan="1" colspan="1">99 (77)</td>
                <td rowspan="1" colspan="1">273 (63)</td>
                <td rowspan="1" colspan="1">20 (41)</td>
                <td rowspan="1" colspan="1">20 (53)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1"><italic toggle="yes">PKD2</italic>, <italic toggle="yes">n</italic> (%)</td>
                <td rowspan="1" colspan="1">31 (13)</td>
                <td rowspan="1" colspan="1">117 (24)</td>
                <td rowspan="1" colspan="1">60 (13)</td>
                <td rowspan="1" colspan="1">172 (19)</td>
                <td rowspan="1" colspan="1">72 (17)</td>
                <td rowspan="1" colspan="1">93 (12)</td>
                <td rowspan="1" colspan="1">25 (15)</td>
                <td rowspan="1" colspan="1">14 (12)</td>
                <td rowspan="1" colspan="1">21 (16)</td>
                <td rowspan="1" colspan="1">90 (21)</td>
                <td rowspan="1" colspan="1">15 (31)</td>
                <td rowspan="1" colspan="1">15 (39)</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Non-<italic toggle="yes">PKD1</italic>, <italic toggle="yes">PKD2</italic>, <italic toggle="yes">n</italic> (%)</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">0</td>
                <td rowspan="1" colspan="1">3 (1)</td>
                <td rowspan="1" colspan="1">9 (18)</td>
                <td rowspan="1" colspan="1">0</td>
              </tr>
              <tr>
                <td rowspan="1" colspan="1">Unsolved, <italic toggle="yes">n</italic> (%)</td>
                <td rowspan="1" colspan="1">56 (23)</td>
                <td rowspan="1" colspan="1">0 (0.0)</td>
                <td rowspan="1" colspan="1">25 (6)</td>
                <td rowspan="1" colspan="1">63 (7)</td>
                <td rowspan="1" colspan="1">0 (0.0)</td>
                <td rowspan="1" colspan="1">21 (3)</td>
                <td rowspan="1" colspan="1">21 (13)</td>
                <td rowspan="1" colspan="1">14 (12)</td>
                <td rowspan="1" colspan="1">9 (7.0)</td>
                <td rowspan="1" colspan="1">70 (16)</td>
                <td rowspan="1" colspan="1">5 (10)</td>
                <td rowspan="1" colspan="1">3 (8)</td>
              </tr>
            </tbody>
          </table>
          <table-wrap-foot>
            <fn fn-type="other">
              <p>ADPKD, autosomal dominant polycystic kidney disease; PKD, polycystic kidney disease.</p>
            </fn>
          </table-wrap-foot>
        </table-wrap>
        <p>Twenty percent of this cohort&#x2014;ascertained based on severe PLD&#x2014;had pathogenic variants in non-<italic toggle="yes">PKD1</italic>/<italic toggle="yes">PKD2</italic> genes (Figure <xref rid="fig2" ref-type="fig">2</xref> and Table <xref rid="t1" ref-type="table">1</xref>). <italic toggle="yes">PRKCSH</italic> contained the pathogenic variant in 5 of 44 (11.4%) patients, <italic toggle="yes">GANAB</italic> in 2 of 44 (5%) patients, <italic toggle="yes">SEC63</italic> in 1 of 44 (2%) patients, and <italic toggle="yes">ALG8</italic> in 1 of 44 (2%) patients. Relatedness analysis found an unexpected relationship between patient 36 and patient 37, where the patients appear to be either third-degree or fourth-degree relatives. This was the only close familial relationship detected in the cohort. Two of the called variants (one in <italic toggle="yes">PRKCSH</italic>, one in <italic toggle="yes">ALG8</italic>) were large heterozygous deletions found from whole exome data and validated with genomic quantitative PCR for this study.</p>
      </sec>
      <sec>
        <title>Clinical Characteristics between Genotypes</title>
        <p>We next compared clinical characteristics between those non-<italic toggle="yes">PKD1</italic>/<italic toggle="yes">PKD2</italic> patients (<italic toggle="yes">n</italic>=9) and the <italic toggle="yes">PKD1</italic>/<italic toggle="yes">PKD2</italic> patients (<italic toggle="yes">n</italic>=35). We found no significant difference in hTLVs, which were 3437 (range, 1960&#x2013;8211) ml/m and 4431 (range, 1817&#x2013;9148) ml/m, respectively, <italic toggle="yes">P</italic> value = 0.77. The number and types of interventions pursued for symptomatic management of PLD management were similar (<ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Tables 1</ext-link> and <ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">2</ext-link>). All of the patients with <italic toggle="yes">GANAB</italic>, <italic toggle="yes">PRKCSH</italic>, <italic toggle="yes">SEC63</italic>, or <italic toggle="yes">ALG8</italic> variants were indicated by their clinician as having PLD without polycystic kidney disease (PKD) (hTKV &lt;250 ml/m), although several have a small number of kidney cysts (Table <xref rid="t1" ref-type="table">1</xref>). The non-<italic toggle="yes">PKD1/PKD2</italic> group's mean hTKV was 179 (range, 138&#x2013;234) ml/m compared with 607 (range, 190&#x2013;2842) ml/m in the <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> group (<italic toggle="yes">P</italic> value &lt; 0.01), and only one <italic toggle="yes">PKD1</italic> and two <italic toggle="yes">PKD2</italic> patients had hTKV &lt;250 ml/m (Figure <xref rid="fig3" ref-type="fig">3</xref> and <ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 2</ext-link>). There was no significant correlation between hTLV and hTKV in each group (Figure <xref rid="fig3" ref-type="fig">3</xref>).</p>
        <fig position="float" id="fig3" fig-type="figure">
          <label>Figure 3</label>
          <caption>
            <p><bold>hTLV and hTKV by genotype.</bold> hTKV and hTLV measurements were calculated from the initial MRI or CT images available at enrollment. Each patient provides one datapoint. Datapoints are on separate plots based on disease genes determined after WES analysis. There was no significant correlation between hTLV and hTKV in each group; 0.37 (95% CI, &#x2212;0.08 to 0.69) in <italic toggle="yes">PKD1</italic> patients, 0.28 (95% CI, &#x2212;0.27 to 0.70) in <italic toggle="yes">PKD2</italic> patients, and 0.05 (95% CI, &#x2212;0.64 to 0.69) in non-<italic toggle="yes">PKD1/PKD2</italic> patients. A threshold of hTKV &lt;250 ml/m (vertical line) would include all <italic toggle="yes">GANAB</italic>, <italic toggle="yes">PRKCSH</italic>, <italic toggle="yes">SEC63</italic>, or <italic toggle="yes">ALG8</italic> patients in this cohort and one <italic toggle="yes">PKD1</italic> and two <italic toggle="yes">PKD2</italic> patients and may be used to predict whether unsolved patients might be expected to be missed <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> variants versus another gene. The horizontal line represents hTLV 1800 ml/m. CI, confidence interval; CT, computed tomography; hTKV, height-adjusted total kidney volume; WES, whole exome sequencing.</p>
          </caption>
          <graphic xlink:href="kidney360-5-1106-g004" position="float"/>
        </fig>
      </sec>
      <sec sec-type="subjects">
        <title>Clinical Comparison between <italic toggle="yes">PKD1</italic> and <italic toggle="yes">PKD2</italic> Patients</title>
        <p>Compared with those with the <italic toggle="yes">PKD1</italic> variant, patients with <italic toggle="yes">PKD2</italic> had more mild kidney parameters including smaller hTKV (332 [range, 202&#x2013;1194] ml/m, 691 [range, 190&#x2013;2842] ml/m, <italic toggle="yes">P</italic> value = 0.02) and lower serum creatinine level (0.70 [range, 0.50&#x2013;1.80] mg/dl, 1.08 [range, 0.55&#x2013;13.80] mg/dl, <italic toggle="yes">P</italic> value = 0.01). Liver parameters were similar between these two groups. hTLV was slightly higher in <italic toggle="yes">PKD1</italic> patients than in <italic toggle="yes">PKD2</italic> patients, but this difference was not significant (NS) (5086 [1912&#x2013;9148] ml/m, 4162 [1817&#x2013;6051] ml/m, <italic toggle="yes">P</italic> = 0.16) and may be influenced by the slightly later age at enrollment of <italic toggle="yes">PKD1</italic> patients. The one exception is that liver function test alanine aminotransferase was higher in patients with <italic toggle="yes">PKD2</italic> (18 [10&#x2013;75] versus 13 [6&#x2013;68], <italic toggle="yes">P</italic>=0.01) (Table <xref rid="t1" ref-type="table">1</xref> and <ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 3</ext-link>).</p>
      </sec>
      <sec>
        <title>Assessment of Liver Size and Growth Rate with Age</title>
        <p>There was no significant difference between the predicted growth rate in patients with <italic toggle="yes">GANAB</italic>, <italic toggle="yes">PRKCSH</italic>, <italic toggle="yes">SEC63</italic>, or <italic toggle="yes">ALG8</italic> pathogenic variants compared with those with <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> variants (4.6 [range, 2.5&#x2013;5.8]%/yr versus 5.2 [range 2.3&#x2013;14.0]%/yr) (<italic toggle="yes">P</italic>=0.17) (Figure <xref rid="fig4" ref-type="fig">4</xref> and <ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 2</ext-link>). As it has been reported that the trajectory of hTLV does not always progress linearly,<sup><xref rid="B25" ref-type="bibr">25</xref></sup> we analyzed the series of CT images of patients where imaging was available at multiple time points without procedural interventions for assessment of the progression of hTLV (Figure <xref rid="fig5" ref-type="fig">5</xref>). The serial volumetry data were obtained from 21 patients, representing <italic toggle="yes">PKD1</italic>, <italic toggle="yes">PKD2</italic>, and <italic toggle="yes">PRKCSH</italic> patients. The median age available for serial data was 59 years (range, 49&#x2013;76), and 14 patients (67%) were female (<ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 4</ext-link>).</p>
        <fig position="float" id="fig4" fig-type="figure">
          <label>Figure 4</label>
          <caption>
            <p><bold>Relationship between hTLV and age at imaging.</bold> hTLV versus age plotted separately depending on disease gene. The oblique line represents 5% per year of hTLV growth.</p>
          </caption>
          <graphic xlink:href="kidney360-5-1106-g005" position="float"/>
        </fig>
        <fig position="float" id="fig5" fig-type="figure">
          <label>Figure 5</label>
          <caption>
            <p><bold>Serial measurements of hTLV.</bold> hTLV values for patients with at least two imaging studies suitable for hTLV calculation without intervening interventions. Red indicates female, and blue indicates male.</p>
          </caption>
          <graphic xlink:href="kidney360-5-1106-g006" position="float"/>
        </fig>
      </sec>
      <sec>
        <title>
<italic toggle="yes">PLD</italic>-Dominant ADPKD Cases</title>
        <p>Among the <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> patients, we noted one <italic toggle="yes">PKD1</italic> patient and two <italic toggle="yes">PKD2</italic> patients with hTKV &lt;250 ml/m at the age of 49&#x2013;59 years despite severe PLD&#x2014;in other words, they had a PLD-dominant phenotype with unusually mild PKD albeit still meeting ADPKD clinical diagnosis. Each of these patients were female. The <italic toggle="yes">PKD1</italic> patient (patient 18), attributed to a <italic toggle="yes">PKD1</italic> p.Tyr1441Cys variant, was diagnosed with PLD when she was 46 years and had numerous small cysts in the kidney, and at age 59 years, hTKV was 190 ml/m whereas hTLV was 2209 ml/m (Figure <xref rid="fig6" ref-type="fig">6</xref>A). Her kidney function was within normal range, but she had hypertension. Patient 35, carrying the pathogenic <italic toggle="yes">PKD2</italic> p.Arg592X variant, was diagnosed with PLD when she was 37 years, and imaging at age 50 years showed hKTV was 210 ml/m while her hTLV was 2936 ml/m. She had two childbirths with two gravidae and never used oral contraceptives. Her hTLV was symptomatic; therefore, a transarterial embolization of liver arteries was conducted at age 50 years (Figure <xref rid="fig6" ref-type="fig">6</xref>B). Patient 24, carrying the pathogenic <italic toggle="yes">PKD2</italic> p.Arg803X variant, was diagnosed with PLD when she was 49 years old, and imaging at that time showed hTKV of 202 ml/m and hTLV of 1817 ml/m. She had experienced three child births with three gravidae and never used oral contraceptives.</p>
        <fig position="float" id="fig6" fig-type="figure">
          <label>Figure 6</label>
          <caption>
            <p><bold>Patients of interest attributable to <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> variants.</bold> (A) Patient 18, <italic toggle="yes">PKD1</italic> variant (p.Tyr1441Cys). A 46-year-old woman with hTKV of 190 ml/m and hTLV of 2209 ml/m. Her kidney function is within normal range, although she has hypertension. (B) Patient 35, <italic toggle="yes">PKD2</italic> variant (p.Arg592X). A 50-year-old woman with hTKV of 210 ml/m and hTLV of 2936 ml/m. (C) Patient 19, <italic toggle="yes">PKD1</italic> variant (p.Thr3049Ile)&#x2014;GPS-cleavage site. A 50-year-old woman with hKTV of 435 ml/m and hTLV of 3055 ml/m.</p>
          </caption>
          <graphic xlink:href="kidney360-5-1106-g007" position="float"/>
        </fig>
      </sec>
      <sec sec-type="subjects">
        <title>First Report of Patient with a Variant in G-Protein&#x2013;Coupled Receptor Proteolytic Site Cleavage Site</title>
        <p>The mature functional PC1 is known to exist as a cleaved protein. <italic toggle="yes">In vitro</italic> studies and mouse models have been made to study the consequence of missense variant at the G-protein&#x2013;coupled receptor proteolytic site cleavage site (orthologs of human p.Leu3048His and p.Thr3049Val).<sup><xref rid="B38" ref-type="bibr">38</xref></sup> The mouse model of p.Leu3048His was embryonically lethal, and despite sufficient expression of uncleaved PC1 in the kidney, the phenotype upon conditional inactivation was no different than truncating models with comparable induction.<sup><xref rid="B39" ref-type="bibr">39</xref></sup> In contrast, mice with the ortholog of p.Thr3049Val studied by a different group survived embryogenesis, suggesting a hypomorphic consequence.<sup><xref rid="B39" ref-type="bibr">39</xref>,<xref rid="B40" ref-type="bibr">40</xref></sup> One of our patients carries a <italic toggle="yes">PKD1</italic> p.Thr3049Ile variant (Table <xref rid="t1" ref-type="table">1</xref>). This is the first human case reported with a GPS cleavage site variant to our knowledge. There are no patients with variants affecting p.Leu3048 or p.Thr3049 in the Mayo database,<sup><xref rid="B41" ref-type="bibr">41</xref></sup> and incomplete information is available for reports of p.Leu3048Phe, p.Leu3048Arg, and p.Thr3049Ile in ClinVar<sup><xref rid="B42" ref-type="bibr">42</xref></sup> and Genome Browser.<sup><xref rid="B43" ref-type="bibr">43</xref></sup> This female patient was diagnosed at age 44 years and had hTKV of 435 ml/m and hTLV of 3055 ml/m at age 50 years (patient 19) (Table <xref rid="t1" ref-type="table">1</xref>). Her increased hTKV appeared mainly attributable to a smaller number of large cysts, and renal calculi were notable (Figure <xref rid="fig6" ref-type="fig">6</xref>C). Based on what is known about this amino acid position and the lack of alternative pathogenic variants in this patient with a definitive clinical diagnosis of ADPKD, we are confident that this variant is pathogenic to her disease. Her kidney disease could be classified as mild (Mayo Classification class 1B<sup><xref rid="B44" ref-type="bibr">44</xref></sup>) as her serum creatinine was only 0.55 mg/dl at age 50 years. Yet, the phenotype appears consistent with that expected from a fully penetrant pathogenic allele. Her PLD was symptomatic, and she underwent transarterial embolization of a liver artery at age 50 years.</p>
      </sec>
    </sec>
    <sec sec-type="discussion" id="s5">
      <title>Discussion</title>
      <p>In this genetic analysis for severe PLD, we found that most cases occurred in the context of ADPKD and that the clinical diagnosis of ADPKD was specific to <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> genotype. Nonetheless, genetically confirmed ADPLD&#x2014;a disease thought to be much rarer than ADPKD&#x2014;was the cause of 20% of genetically explained severe PLD in our nephrology center. This demonstrates that ADPLD is an important contributor to the population burden of severe PLD. Factors to consider which may affect the composition of our cohort are anything affecting patient motivation to participate&#x2014;although the participation rate was the same approximately 34% from both the ADPKD and ADPLD phenotype groups, indication for abdominal imaging suitable for hTLV calculation, and indication for referral to our center that provides consideration of interventional therapies. Nonetheless, this cohort is unique in its inclusion of ADPLD patients, genetic information, and many interventions.</p>
      <p>A striking finding from our genetic analysis is the apparent enrichment of <italic toggle="yes">PKD2</italic> patients in this uniquely selected cohort compared with previously published ADPKD cohorts from Japan or other countries. In this study, <italic toggle="yes">PKD2</italic> variants were found in 39% of the clinically defined ADPKD patients. <italic toggle="yes">PKD2</italic> typically accounts for 12%&#x2013;24%, whereas those with <italic toggle="yes">PKD1</italic> account for 63%&#x2013;85% <sup><xref rid="B25" ref-type="bibr">25</xref>,<xref rid="B45" ref-type="bibr">45</xref><xref rid="B46" ref-type="bibr"/><xref rid="B47" ref-type="bibr"/><xref rid="B48" ref-type="bibr"/>&#x2013;<xref rid="B49" ref-type="bibr">49</xref></sup> (Table <xref rid="t2" ref-type="table">2</xref>). In Asian cohorts, the rates of the <italic toggle="yes">PKD1</italic> and <italic toggle="yes">PKD2</italic> variants are similar to those of previous studies.<sup><xref rid="B50" ref-type="bibr">50</xref><xref rid="B51" ref-type="bibr"/><xref rid="B52" ref-type="bibr"/>&#x2013;<xref rid="B53" ref-type="bibr">53</xref></sup> This cohort was selected before any genetic assessment and without considering kidney status. Although PLD in <italic toggle="yes">PKD2</italic> patients was no more severe than in <italic toggle="yes">PKD1</italic> patients&#x2014;consistent with published findings in other cohorts&#x2014;one explanation of our prevalent <italic toggle="yes">PKD2</italic> patients could be that severe PLD is more prevalent among <italic toggle="yes">PKD2</italic> patients, thus enriching this genotype in ADPKD cohorts defined based on severe PLD.<sup><xref rid="B25" ref-type="bibr">25</xref></sup></p>
      <p>Although not all kidneys with cysts in this cohort were enlarged, variants in <italic toggle="yes">GANAB</italic>, <italic toggle="yes">ALG8</italic>, <italic toggle="yes">ALG9</italic>, and <italic toggle="yes">DNAJB11</italic> may cause phenotypes ranging from clinically suspected ADPKD to ADPLD, although they did not meet accepted clinical diagnostic criteria for ADPKD. In these patients, hTKV was consistently &lt;250 ml/m, whereas this was true for only 3 of 35 patients with a <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> variant (PLD-dominant ADPKD patients). This suggests that hTKV &gt;250 ml/m could be a logical threshold above which suspicion should be high for <italic toggle="yes">PKD1</italic> or <italic toggle="yes">PKD2</italic> variants.</p>
      <p>In this cohort, we found a novel <italic toggle="yes">PKD1</italic> p.Tyr1441Cys missense variant from a patient with severe PLD but relatively mild PKD. This variant is predicted to affect a single amino acid in one of the PKD domains of the extracellular N terminus of PC1. It will be interesting whether future cases with this variant identified in the future or the patient's family also have mild kidney disease. Our patient with the novel GPS cleavage site variant <italic toggle="yes">PKD1</italic> p.Tyr3049Ile has a less mild kidney disease, with hTKV of &gt;400 ml/m in addition to severe PLD, suggesting that this novel GPS cleavage site variant has a fully penetrant pathogenic consequence in humans, a finding that provides clarity to the mouse model investigations that posed this question.<sup><xref rid="B38" ref-type="bibr">38</xref>,<xref rid="B39" ref-type="bibr">39</xref></sup></p>
      <p>The female predominance described in clinically apparent PLD is indeed confirmed in our cohort similar with percentages similar to other cohorts. In our cohort of severe PLD, 80% of the 38 patients with ADPKD, and 73% of the 11 patients with ADPLD, are female. This is similar to 83% of the 101 ADPKD patients with severe PLD described by Chebib <italic toggle="yes">et al.</italic><sup><xref rid="B25" ref-type="bibr">25</xref></sup> and the 76% of 201 ADPLD patients described by Sch&#xF6;nauer <italic toggle="yes">et al.</italic><sup><xref rid="B54" ref-type="bibr">54</xref></sup> Compared with the Schonauer cohort, our cohort has higher mean hTLV despite slightly lower mean age at assessment.</p>
      <p>The strength of this study is that we recruited based on severe PLD without regard to ADPKD status and evaluated both ADPKD- and ADPLD-related genes without prior clinical information. In being the first study to our knowledge to take this approach, we define the genetic basis of severe PLD, although the number of patients is small and from only a subset of the eligible population in two referral centers in Japan. Furthermore, although we propose an intriguing enrichment of <italic toggle="yes">PKD2</italic> patients in this cohort, we interpret this enrichment compared with ratios (<italic toggle="yes">PKD1</italic>:<italic toggle="yes">PKD2</italic>:Unsolved) in historical cohorts and not our study population because genetic data for this &#x201C;true reference&#x201D; ADPKD population are not available.</p>
      <p>In conclusion, we describe <italic toggle="yes">PKD1</italic>, <italic toggle="yes">PKD2</italic>, <italic toggle="yes">PRKCSH</italic>, <italic toggle="yes">GANAB</italic>, <italic toggle="yes">SEC63</italic>, and <italic toggle="yes">ALG8</italic> as disease genes contributing to the burden of severe PLD in a Japanese population. We confirm prior findings that liver cyst severity may be independent of kidney cyst severity and that genotype does not predict severity. We find an apparent enrichment in <italic toggle="yes">PKD2</italic> patients and propose that severe PLD may be more prevalent in <italic toggle="yes">PKD2</italic>-related ADPKD.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplementary Material</title>
      <fig id="s001" position="anchor">
        <media xlink:href="kidney360-5-1106-s001.pdf"/>
      </fig>
      <fig id="s002" position="anchor">
        <media xlink:href="kidney360-5-1106-s002.pdf"/>
      </fig>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="equal">
        <p>H.M. and W.B. contributed equally to this work.</p>
      </fn>
    </fn-group>
    <sec sec-type="COI-statement">
      <title>Disclosures</title>
      <p>Disclosure forms, as provided by each author, are available with the online version of the article at <ext-link xlink:href="http://links.lww.com/KN9/A513" ext-link-type="uri">http://links.lww.com/KN9/A513</ext-link>.</p>
    </sec>
    <sec sec-type="funding">
      <title>Funding</title>
      <p>H. Mizuno: Okinaka Memorial Institute for Medical Research. W. Besse: NIH/NIDDK K08DK119642. Yale Center for Mendelian Genomics (CMG): NIH M#UM1HG006504-05. J Hoshino:MHLW Research Program on Intractable Kidney Disease (JPMH23FC1048) Intractable Hepatobiliary Disease (JPMH20FC1023), and JSPS KAKENHI 18K08227 and 24K11440.</p>
    </sec>
    <sec sec-type="author-contributions">
      <title>Author Contributions</title>
      <p><bold>Conceptualization:</bold> Whitney Besse, Junichi Hoshino, Hiroki Mizuno, Akinari Sekine, Stefan Somlo, Yoshifumi Ubara.</p>
      <p><bold>Data curation:</bold> Whitney Besse, Eiko Hasegawa, Junichi Hoshino, Shigekazu Kurihara, Hiroki Mizuno, Yuki Oba, Naoki Sawa, Akinari Sekine, Tatsuya Suwabe, Yoshifumi Ubara, Masayuki Yamanouchi.</p>
      <p><bold>Formal analysis:</bold> Whitney Besse, Hiroki Mizuno, Akinari Sekine.</p>
      <p><bold>Funding acquisition:</bold> Whitney Besse.</p>
      <p><bold>Investigation:</bold> Whitney Besse, Junichi Hoshino, Kelly T. Long, Hiroki Mizuno.</p>
      <p><bold>Methodology:</bold> Whitney Besse, Junichi Hoshino, Hiroki Mizuno.</p>
      <p><bold>Project administration:</bold> Whitney Besse, Hiroki Mizuno.</p>
      <p><bold>Resources:</bold> Whitney Besse, Hiroki Mizuno.</p>
      <p><bold>Software:</bold> Whitney Besse, Hiroki Mizuno.</p>
      <p><bold>Supervision:</bold> Junichi Hoshino, Stefan Somlo.</p>
      <p><bold>Validation:</bold> Whitney Besse, Junichi Hoshino, Hiroki Mizuno.</p>
      <p><bold>Visualization:</bold> Whitney Besse, Junichi Hoshino, Hiroki Mizuno, Akinari Sekine.</p>
      <p><bold>Writing original draft:</bold> Whitney Besse, Junichi Hoshino, Hiroki Mizuno.</p>
      <p><bold>Writing review &amp; editing:</bold> Whitney Besse, Eiko Hasegawa, Junichi Hoshino, Shigekazu Kurihara, Hiroki Mizuno, Yuki Oba, Naoki Sawa, Akinari Sekine, Stefan Somlo, Tatsuya Suwabe, Yoshifumi Ubara, Masayuki Yamanouchi.</p>
    </sec>
    <sec sec-type="data-availability">
      <title>Data Sharing Statement</title>
      <p>All data are included in the manuscript and/or supporting information.</p>
    </sec>
    <sec sec-type="supplementary-material">
      <title>Supplemental Material</title>
      <p>This article contains the following supplemental material online at <ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">http://links.lww.com/KN9/A512</ext-link>.</p>
      <p><ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 1</ext-link>. History of interventions to polycystic liver cyst.</p>
      <p><ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 2</ext-link>. Clinical characteristics of <italic toggle="yes">PKD1</italic>/<italic toggle="yes">PKD2</italic> variants group and ADPLD-related variants group. ADPLD-related variants group included patients with <italic toggle="yes">PRKCSH</italic>, <italic toggle="yes">SEC63</italic>, <italic toggle="yes">GANAB</italic>, and <italic toggle="yes">ALG8</italic>. Continuous variables are described by median and range.</p>
      <p><ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 3</ext-link>. Clinical characteristics of each variant group.</p>
      <p><ext-link xlink:href="http://links.lww.com/KN9/A512" ext-link-type="uri">Supplemental Table 4</ext-link>. Longitudinal volumetrics of hTLV before intervention.</p>
    </sec>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornec-Le Gall</surname><given-names>E</given-names></name>
<name><surname>Torres</surname><given-names>VE</given-names></name>
<name><surname>Harris</surname><given-names>PC</given-names></name></person-group>. <article-title>Genetic complexity of autosomal dominant polycystic kidney and liver diseases</article-title>. <source>J Am Soc Nephrol.</source>
<year>2018</year>;<volume>29</volume>(<issue>1</issue>):<fpage>13</fpage>&#x2013;<lpage>23</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2017050483</pub-id><pub-id pub-id-type="pmid">29038287</pub-id>
</mixed-citation>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>KT</given-names></name>
<name><surname>Zhu</surname><given-names>F</given-names></name>
<name><surname>Chapman</surname><given-names>AB</given-names></name>, <etal/></person-group>.; <collab>Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease (CRISP)</collab>. <article-title>Magnetic resonance imaging evaluation of hepatic cysts in early autosomal-dominant polycystic kidney disease: the consortium for radiologic imaging studies of polycystic kidney disease cohort</article-title>. <source>Clin J Am Soc Nephrol.</source>
<year>2006</year>;<volume>1</volume>(<issue>1</issue>):<fpage>64</fpage>&#x2013;<lpage>69</lpage>. doi:<pub-id pub-id-type="doi">10.2215/CJN.00080605</pub-id><pub-id pub-id-type="pmid">17699192</pub-id>
</mixed-citation>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>VE</given-names></name>
<name><surname>Harris</surname><given-names>PC</given-names></name></person-group>. <article-title>Autosomal dominant polycystic kidney disease: the last 3 years</article-title>. <source>Kidney Int.</source>
<year>2009</year>;<volume>76</volume>(<issue>2</issue>):<fpage>149</fpage>&#x2013;<lpage>168</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ki.2009.128</pub-id><pub-id pub-id-type="pmid">19455193</pub-id>
</mixed-citation>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Van Keimpema</surname><given-names>L</given-names></name>
<name><surname>De Koning</surname><given-names>DB</given-names></name>
<name><surname>Van Hoek</surname><given-names>B</given-names></name>, <etal/></person-group>. <article-title>Patients with isolated polycystic liver disease referred to liver centres: clinical characterization of 137 cases</article-title>. <source>Liver Int.</source>
<year>2011</year>;<volume>31</volume>(<issue>1</issue>):<fpage>92</fpage>&#x2013;<lpage>98</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1478-3231.2010.02247.x</pub-id><pub-id pub-id-type="pmid">20408955</pub-id>
</mixed-citation>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Suwabe</surname><given-names>T</given-names></name>
<name><surname>Chamberlain</surname><given-names>AM</given-names></name>
<name><surname>Killian</surname><given-names>JM</given-names></name>, <etal/></person-group>. <article-title>Epidemiology of autosomal-dominant polycystic liver disease in Olmsted county</article-title>. <source>JHEP Rep.</source><year>2020</year>;<volume>2</volume>(<issue>6</issue>):<fpage>100166</fpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jhepr.2020.100166</pub-id><pub-id pub-id-type="pmid">33145487</pub-id>
</mixed-citation>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lanktree</surname><given-names>MB</given-names></name>
<name><surname>Haghighi</surname><given-names>A</given-names></name>
<name><surname>Guiard</surname><given-names>E</given-names></name>, <etal/></person-group>. <article-title>Prevalence estimates of polycystic kidney and liver disease by population sequencing</article-title>. <source>J Am Soc Nephrol.</source>
<year>2018</year>;<volume>29</volume>(<issue>10</issue>):<fpage>2593</fpage>&#x2013;<lpage>2600</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2018050493</pub-id><pub-id pub-id-type="pmid">30135240</pub-id>
</mixed-citation>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Qian</surname><given-names>Q</given-names></name></person-group>. <article-title>Isolated polycystic liver disease</article-title>. <source>Adv Chronic Kidney Dis.</source>
<year>2010</year>;<volume>17</volume>(<issue>2</issue>):<fpage>181</fpage>&#x2013;<lpage>189</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.ackd.2009.12.005</pub-id><pub-id pub-id-type="pmid">20219621</pub-id>
</mixed-citation>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Harris</surname><given-names>PC</given-names></name>
<name><surname>Torres</surname><given-names>VE</given-names></name></person-group>. <article-title>Polycystic kidney disease</article-title>. <source>Annu Rev Med.</source>
<year>2009</year>;<volume>60</volume>:<fpage>321</fpage>&#x2013;<lpage>337</lpage>. doi:<pub-id pub-id-type="doi">10.1146/annurev.med.60.101707.125712</pub-id><pub-id pub-id-type="pmid">18947299</pub-id>
</mixed-citation>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rossetti</surname><given-names>S</given-names></name>
<name><surname>Consugar</surname><given-names>MB</given-names></name>
<name><surname>Chapman</surname><given-names>AB</given-names></name>, <etal/></person-group>.; <collab>Consortium and the C</collab>. <article-title>Comprehensive molecular diagnostics in autosomal dominant polycystic kidney disease</article-title>. <source>J Am Soc Nephrol.</source>
<year>2007</year>;<volume>18</volume>(<issue>7</issue>):<fpage>2143</fpage>&#x2013;<lpage>2160</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2006121387</pub-id><pub-id pub-id-type="pmid">17582161</pub-id>
</mixed-citation>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Li</surname><given-names>A</given-names></name>
<name><surname>Davila</surname><given-names>S</given-names></name>
<name><surname>Furu</surname><given-names>L</given-names></name>, <etal/></person-group>. <article-title>Mutations in PRKCSH cause isolated autosomal dominant polycystic liver disease</article-title>. <source>Am J Hum Genet.</source>
<year>2003</year>;<volume>72</volume>(<issue>3</issue>):<fpage>691</fpage>&#x2013;<lpage>703</lpage>. doi:<pub-id pub-id-type="doi">10.1086/368295</pub-id><pub-id pub-id-type="pmid">12529853</pub-id>
</mixed-citation>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Davila</surname><given-names>S</given-names></name>
<name><surname>Furu</surname><given-names>L</given-names></name>
<name><surname>Gharavi</surname><given-names>AG</given-names></name>, <etal/></person-group>. <article-title>Mutations in SEC63 cause autosomal dominant polycystic liver disease</article-title>. <source>Nat Genet.</source>
<year>2004</year>;<volume>36</volume>(<issue>6</issue>):<fpage>575</fpage>&#x2013;<lpage>577</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng1357</pub-id><pub-id pub-id-type="pmid">15133510</pub-id>
</mixed-citation>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besse</surname><given-names>W</given-names></name>
<name><surname>Dong</surname><given-names>K</given-names></name>
<name><surname>Choi</surname><given-names>J</given-names></name>, <etal/></person-group>. <article-title>Isolated polycystic liver disease genes define effectors of polycystin-1 function</article-title>. <source>J Clin Invest.</source>
<year>2017</year>;<volume>127</volume>(<issue>9</issue>):<fpage>3558</fpage>&#x2013;<lpage>1785</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI96729</pub-id><pub-id pub-id-type="pmid">28862642</pub-id>
</mixed-citation>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Besse</surname><given-names>W</given-names></name>
<name><surname>Chang</surname><given-names>AR</given-names></name>
<name><surname>Luo</surname><given-names>JZ</given-names></name>, <etal/></person-group>.; <collab>Regeneron Genetics Center</collab>. <article-title>ALG9 mutation carriers develop kidney and liver cysts</article-title>. <source>J Am Soc Nephrol.</source>
<year>2019</year>;<volume>30</volume>(<issue>11</issue>):<fpage>2091</fpage>&#x2013;<lpage>2102</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2019030298</pub-id><pub-id pub-id-type="pmid">31395617</pub-id>
</mixed-citation>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Porath</surname><given-names>B</given-names></name>
<name><surname>Gainullin</surname><given-names>VG</given-names></name>
<name><surname>Cornec-Le Gall</surname><given-names>E</given-names></name>, <etal/></person-group>.; <collab>Genkyst Study Group, HALT Progression of Polycystic Kidney Disease Group, Consortium for Radiologic Imaging Studies of Polycystic Kidney Disease</collab>. <article-title>Mutations in GANAB, encoding the glucosidase II&#x3B1; subunit, cause autosomal-dominant polycystic kidney and liver disease</article-title>. <source>Am J Hum Genet.</source>
<year>2016</year>;<volume>98</volume>(<issue>6</issue>):<fpage>1193</fpage>&#x2013;<lpage>1207</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.05.004</pub-id><pub-id pub-id-type="pmid">27259053</pub-id>
</mixed-citation>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Gonzalez</surname><given-names>MA</given-names></name>
<name><surname>Menezes</surname><given-names>LF</given-names></name>
<name><surname>Piontek</surname><given-names>KB</given-names></name>, <etal/></person-group>. <article-title>Genetic interaction studies link autosomal dominant and recessive polycystic kidney disease in a common pathway</article-title>. <source>Hum Mol Genet.</source>
<year>2007</year>;<volume>16</volume>:<fpage>1940</fpage>&#x2013;<lpage>1950</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddm141</pub-id><pub-id pub-id-type="pmid">17575307</pub-id>
</mixed-citation>
      </ref>
      <ref id="B16">
        <label>16.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Fedeles</surname><given-names>SV</given-names></name>
<name><surname>Tian</surname><given-names>X</given-names></name>
<name><surname>Gallagher</surname><given-names>A-R</given-names></name>, <etal/></person-group>. <article-title>A genetic interaction network of five genes for human polycystic kidney and liver diseases defines polycystin-1 as the central determinant of cyst formation</article-title>. <source>Nat Genet.</source>
<year>2011</year>;<volume>43</volume>(<issue>7</issue>):<fpage>639</fpage>&#x2013;<lpage>647</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.860</pub-id><pub-id pub-id-type="pmid">21685914</pub-id>
</mixed-citation>
      </ref>
      <ref id="B17">
        <label>17.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoevenaren</surname><given-names>IA</given-names></name>
<name><surname>Wester</surname><given-names>R</given-names></name>
<name><surname>Schrier</surname><given-names>RW</given-names></name>, <etal/></person-group>. <article-title>Polycystic liver: clinical characteristics of patients with isolated polycystic liver disease compared with patients with polycystic liver and autosomal dominant polycystic kidney disease</article-title>. <source>Liver Int.</source>
<year>2008</year>;<volume>28</volume>(<issue>2</issue>):<fpage>264</fpage>&#x2013;<lpage>270</lpage>. doi:<pub-id pub-id-type="doi">10.1111/j.1478-3231.2007.01595.x</pub-id><pub-id pub-id-type="pmid">17927714</pub-id>
</mixed-citation>
      </ref>
      <ref id="B18">
        <label>18.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bae</surname><given-names>KT</given-names></name>
<name><surname>Tao</surname><given-names>C</given-names></name>
<name><surname>Feldman</surname><given-names>R</given-names></name>, <etal/></person-group>.; <collab>CRISP and HALT PKD Consortium</collab>. <article-title>Volume progression and imaging classification of polycystic liver in early autosomal dominant polycystic kidney disease</article-title>. <source>Clin J Am Soc Nephrol.</source>
<year>2022</year>;<volume>17</volume>(<issue>3</issue>):<fpage>374</fpage>&#x2013;<lpage>384</lpage>. doi:<pub-id pub-id-type="doi">10.2215/CJN.08660621</pub-id><pub-id pub-id-type="pmid">35217526</pub-id>
</mixed-citation>
      </ref>
      <ref id="B19">
        <label>19.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chebib</surname><given-names>FT</given-names></name>
<name><surname>Harmon</surname><given-names>A</given-names></name>
<name><surname>Irazabal Mira</surname><given-names>MV</given-names></name>, <etal/></person-group>. <article-title>Outcomes and durability of hepatic reduction after combined partial hepatectomy and cyst fenestration for massive polycystic liver disease</article-title>. <source>J Am Coll Surg.</source>
<year>2016</year>;<volume>223</volume>(<issue>1</issue>):<fpage>118</fpage>&#x2013;<lpage>126e1</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.jamcollsurg.2015.12.051</pub-id><pub-id pub-id-type="pmid">27016902</pub-id>
</mixed-citation>
      </ref>
      <ref id="B20">
        <label>20.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ueno</surname><given-names>T</given-names></name>
<name><surname>Barri</surname><given-names>YM</given-names></name>
<name><surname>Netto</surname><given-names>GJ</given-names></name>, <etal/></person-group>. <article-title>Liver and kidney transplantation for polycystic liver and kidney-renal function and outcome</article-title>. <source>Transplantation.</source>
<year>2006</year>;<volume>82</volume>(<issue>4</issue>):<fpage>501</fpage>&#x2013;<lpage>507</lpage>. doi:<pub-id pub-id-type="doi">10.1097/01.tp.0000231712.75645.7a</pub-id><pub-id pub-id-type="pmid">16926594</pub-id>
</mixed-citation>
      </ref>
      <ref id="B21">
        <label>21.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Schnelldorfer</surname><given-names>T</given-names></name>
<name><surname>Torres</surname><given-names>VE</given-names></name>
<name><surname>Zakaria</surname><given-names>S</given-names></name>
<name><surname>Rosen</surname><given-names>CB</given-names></name>
<name><surname>Nagorney</surname><given-names>DM</given-names></name></person-group>. <article-title>Polycystic liver disease: a critical appraisal of hepatic resection, cyst fenestration, and liver transplantation</article-title>. <source>Ann Surg.</source>
<year>2009</year>;<volume>250</volume>(<issue>1</issue>):<fpage>112</fpage>&#x2013;<lpage>118</lpage>. doi:<pub-id pub-id-type="doi">10.1097/SLA.0b013e3181ad83dc</pub-id><pub-id pub-id-type="pmid">19561475</pub-id>
</mixed-citation>
      </ref>
      <ref id="B22">
        <label>22.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Pirenne</surname><given-names>J</given-names></name>
<name><surname>Aerts</surname><given-names>R</given-names></name>
<name><surname>Yoong</surname><given-names>K</given-names></name>, <etal/></person-group>. <article-title>Liver transplantation for polycystic liver disease</article-title>. <source>Liver Transpl.</source>
<year>2001</year>;<volume>7</volume>(<issue>3</issue>):<fpage>238</fpage>&#x2013;<lpage>245</lpage>. doi:<pub-id pub-id-type="doi">10.1053/jlts.2001.22178</pub-id><pub-id pub-id-type="pmid">11244166</pub-id>
</mixed-citation>
      </ref>
      <ref id="B23">
        <label>23.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornec-Le Gall</surname><given-names>E</given-names></name>
<name><surname>Audr&#xE9;zet</surname><given-names>M-P</given-names></name>
<name><surname>Chen</surname><given-names>J-M</given-names></name>, <etal/></person-group>. <article-title>Type of PKD1 mutation influences renal outcome in ADPKD</article-title>. <source>J Am Soc Nephrol.</source>
<year>2013</year>;<volume>24</volume>(<issue>6</issue>):<fpage>1006</fpage>&#x2013;<lpage>1013</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2012070650</pub-id><pub-id pub-id-type="pmid">23431072</pub-id>
</mixed-citation>
      </ref>
      <ref id="B24">
        <label>24.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Heyer</surname><given-names>CM</given-names></name>
<name><surname>Sundsbak</surname><given-names>JL</given-names></name>
<name><surname>Abebe</surname><given-names>KZ</given-names></name>, <etal/></person-group>.; <collab>HALT PKD and CRISP Investigators</collab>. <article-title>For the HALT PKD and CRISP investigators: predicted mutation strength of nontruncating PKD1 mutations aids genotype-phenotype correlations in autosomal dominant polycystic kidney disease</article-title>. <source>J Am Soc Nephrol.</source>
<year>2016</year>;<volume>27</volume>(<issue>9</issue>):<fpage>2872</fpage>&#x2013;<lpage>2884</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2015050583</pub-id><pub-id pub-id-type="pmid">26823553</pub-id>
</mixed-citation>
      </ref>
      <ref id="B25">
        <label>25.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chebib</surname><given-names>FT</given-names></name>
<name><surname>Jung</surname><given-names>Y</given-names></name>
<name><surname>Heyer</surname><given-names>CM</given-names></name>, <etal/></person-group>. <article-title>Effect of genotype on the severity and volume progression of polycystic liver disease in autosomal dominant polycystic kidney disease</article-title>. <source>Nephrol Dial Transplant.</source>
<year>2016</year>;<volume>31</volume>(<issue>6</issue>):<fpage>952</fpage>&#x2013;<lpage>960</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ndt/gfw008</pub-id><pub-id pub-id-type="pmid">26932689</pub-id>
</mixed-citation>
      </ref>
      <ref id="B26">
        <label>26.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kim</surname><given-names>H</given-names></name>
<name><surname>Park</surname><given-names>HC</given-names></name>
<name><surname>Ryu</surname><given-names>H</given-names></name>, <etal/></person-group>. <article-title>Clinical correlates of mass effect in autosomal dominant polycystic kidney disease</article-title>. <source>PLoS One.</source>
<year>2015</year>;<volume>10</volume>(<issue>12</issue>):<fpage>e0144526</fpage>. doi:<pub-id pub-id-type="doi">10.1371/journal.pone.0144526</pub-id><pub-id pub-id-type="pmid">26641645</pub-id>
</mixed-citation>
      </ref>
      <ref id="B27">
        <label>27.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Karczewski</surname><given-names>KJ</given-names></name>
<name><surname>Francioli</surname><given-names>LC</given-names></name>
<name><surname>Tiao</surname><given-names>G</given-names></name>, <etal/></person-group>.; <collab>Genome Aggregation Database Consortium</collab>. <article-title>The mutational constraint spectrum quantified from variation in 141,456 humans</article-title>. <source>Nature.</source>
<year>2020</year>;<volume>581</volume>(<issue>7809</issue>):<fpage>434</fpage>&#x2013;<lpage>443</lpage>. doi:<pub-id pub-id-type="doi">10.1038/s41586-020-2308-7</pub-id><pub-id pub-id-type="pmid">32461654</pub-id>
</mixed-citation>
      </ref>
      <ref id="B28">
        <label>28.</label>
        <mixed-citation publication-type="book"><source>gnomAD [Internet]</source>. <comment>Accessed June 21, 2023. <ext-link xlink:href="https://gnomad.broadinstitute.org/" ext-link-type="uri">https://gnomad.broadinstitute.org/</ext-link></comment></mixed-citation>
      </ref>
      <ref id="B29">
        <label>29.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richards</surname><given-names>S</given-names></name>
<name><surname>Aziz</surname><given-names>N</given-names></name>
<name><surname>Bale</surname><given-names>S</given-names></name>, <etal/></person-group>.; <collab>ACMG Laboratory Quality Assurance Committee</collab>. <article-title>Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology</article-title>. <source>Genet Med.</source>
<year>2015</year>;<volume>17</volume>(<issue>5</issue>):<fpage>405</fpage>&#x2013;<lpage>424</lpage>. doi:<pub-id pub-id-type="doi">10.1038/gim.2015.30</pub-id><pub-id pub-id-type="pmid">25741868</pub-id>
</mixed-citation>
      </ref>
      <ref id="B30">
        <label>30.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kircher</surname><given-names>M</given-names></name>
<name><surname>Witten</surname><given-names>DM</given-names></name>
<name><surname>Jain</surname><given-names>P</given-names></name>
<name><surname>O&#x2019;Roak</surname><given-names>BJ</given-names></name>
<name><surname>Cooper</surname><given-names>GM</given-names></name>
<name><surname>Shendure</surname><given-names>J</given-names></name></person-group>. <article-title>A general framework for estimating the relative pathogenicity of human genetic variants</article-title>. <source>Nat Genet.</source>
<year>2014</year>;<volume>46</volume>(<issue>3</issue>):<fpage>310</fpage>&#x2013;<lpage>315</lpage>. doi:<pub-id pub-id-type="doi">10.1038/ng.2892</pub-id><pub-id pub-id-type="pmid">24487276</pub-id>
</mixed-citation>
      </ref>
      <ref id="B31">
        <label>31.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Dong</surname><given-names>C</given-names></name>
<name><surname>Wei</surname><given-names>P</given-names></name>
<name><surname>Jian</surname><given-names>X</given-names></name>, <etal/></person-group>. <article-title>Comparison and integration of deleteriousness prediction methods for nonsynonymous SNVs in whole exome sequencing studies</article-title>. <source>Hum Mol Genet.</source>
<year>2015</year>;<volume>24</volume>(<issue>8</issue>):<fpage>2125</fpage>&#x2013;<lpage>2137</lpage>. doi:<pub-id pub-id-type="doi">10.1093/hmg/ddu733</pub-id><pub-id pub-id-type="pmid">25552646</pub-id>
</mixed-citation>
      </ref>
      <ref id="B32">
        <label>32.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ioannidis</surname><given-names>NM</given-names></name>
<name><surname>Rothstein</surname><given-names>JH</given-names></name>
<name><surname>Pejaver</surname><given-names>V</given-names></name>, <etal/></person-group>. <article-title>REVEL: an ensemble method for predicting the pathogenicity of rare missense variants</article-title>. <source>Am J Hum Genet.</source>
<year>2016</year>;<volume>99</volume>(<issue>4</issue>):<fpage>877</fpage>&#x2013;<lpage>885</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ajhg.2016.08.016</pub-id><pub-id pub-id-type="pmid">27666373</pub-id>
</mixed-citation>
      </ref>
      <ref id="B33">
        <label>33.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hoshino</surname><given-names>J</given-names></name>
<name><surname>Ubara</surname><given-names>Y</given-names></name>
<name><surname>Suwabe</surname><given-names>T</given-names></name>, <etal/></person-group>. <article-title>Intravascular embolization therapy in patients with enlarged polycystic liver</article-title>. <source>Am J Kidney Dis.</source>
<year>2014</year>;<volume>63</volume>(<issue>6</issue>):<fpage>937</fpage>&#x2013;<lpage>944</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.ajkd.2014.01.422</pub-id><pub-id pub-id-type="pmid">24602778</pub-id>
</mixed-citation>
      </ref>
      <ref id="B34">
        <label>34.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Matsuo</surname><given-names>S</given-names></name>
<name><surname>Imai</surname><given-names>E</given-names></name>
<name><surname>Horio</surname><given-names>M</given-names></name>, <etal/></person-group>.; <collab>Collaborators developing the Japanese equation for estimated GFR</collab>. <article-title>Revised equations for estimated GFR from serum creatinine in Japan</article-title>. <source>Am J Kidney Dis.</source>
<year>2009</year>;<volume>53</volume>(<issue>6</issue>):<fpage>982</fpage>&#x2013;<lpage>992</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.ajkd.2008.12.034</pub-id><pub-id pub-id-type="pmid">19339088</pub-id>
</mixed-citation>
      </ref>
      <ref id="B35">
        <label>35.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Urata</surname><given-names>K</given-names></name>
<name><surname>Kawasaki</surname><given-names>S</given-names></name>
<name><surname>Matsunami</surname><given-names>H</given-names></name>, <etal/></person-group>. <article-title>Calculation of child and adult standard liver volume for liver transplantation</article-title>. <source>Hepatology.</source>
<year>1995</year>;<volume>21</volume>(<issue>5</issue>):<fpage>1317</fpage>&#x2013;<lpage>1321</lpage>. doi:<pub-id pub-id-type="doi">10.1002/hep.1840210515</pub-id><pub-id pub-id-type="pmid">7737637</pub-id>
</mixed-citation>
      </ref>
      <ref id="B36">
        <label>36.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Danecek</surname><given-names>P</given-names></name>
<name><surname>Auton</surname><given-names>A</given-names></name>
<name><surname>Abecasis</surname><given-names>G</given-names></name>, <etal/></person-group>.; <collab>1000 Genomes Project Analysis Group</collab>. <article-title>1000 genomes Project analysis group: the variant call format and VCFtools</article-title>. <source>Bioinformatics.</source>
<year>2011</year>;<volume>27</volume>(<issue>15</issue>):<fpage>2156</fpage>&#x2013;<lpage>2158</lpage>. doi:<pub-id pub-id-type="doi">10.1093/bioinformatics/btr330</pub-id><pub-id pub-id-type="pmid">21653522</pub-id>
</mixed-citation>
      </ref>
      <ref id="B37">
        <label>37.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>C-C</given-names></name>
<name><surname>Lee</surname><given-names>A-F</given-names></name>
<name><surname>Kohl</surname><given-names>S</given-names></name>, <etal/></person-group>.; <collab>Taiwan PKD Consortium</collab>. <article-title>PKD2 founder mutation is the most common mutation of polycystic kidney disease in Taiwan</article-title>. <source>NPJ Genom Med.</source>
<year>2022</year>;<volume>7</volume>(<issue>1</issue>):<fpage>40</fpage>. doi:<pub-id pub-id-type="doi">10.1038/s41525-022-00309-w</pub-id><pub-id pub-id-type="pmid">35778421</pub-id>
</mixed-citation>
      </ref>
      <ref id="B38">
        <label>38.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Yu</surname><given-names>S</given-names></name>
<name><surname>Hackmann</surname><given-names>K</given-names></name>
<name><surname>Gao</surname><given-names>J</given-names></name>, <etal/></person-group>. <article-title>Essential role of cleavage of Polycystin-1 at G protein-coupled receptor proteolytic site for kidney tubular structure</article-title>. <source>Proc Natl Acad Sci U S A.</source>
<year>2007</year>;<volume>104</volume>(<issue>47</issue>):<fpage>18688</fpage>&#x2013;<lpage>18693</lpage>. doi:<pub-id pub-id-type="doi">10.1073/pnas.0708217104</pub-id><pub-id pub-id-type="pmid">18003909</pub-id>
</mixed-citation>
      </ref>
      <ref id="B39">
        <label>39.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cai</surname><given-names>Y</given-names></name>
<name><surname>Fedeles</surname><given-names>SV</given-names></name>
<name><surname>Dong</surname><given-names>K</given-names></name>, <etal/></person-group>. <article-title>Altered trafficking and stability of polycystins underlie polycystic kidney disease</article-title>. <source>J Clin Invest.</source>
<year>2014</year>;<volume>124</volume>(<issue>12</issue>):<fpage>5129</fpage>&#x2013;<lpage>5144</lpage>. doi:<pub-id pub-id-type="doi">10.1172/JCI67273</pub-id><pub-id pub-id-type="pmid">25365220</pub-id>
</mixed-citation>
      </ref>
      <ref id="B40">
        <label>40.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Trudel</surname><given-names>M</given-names></name>
<name><surname>Yao</surname><given-names>Q</given-names></name>
<name><surname>Qian</surname><given-names>F</given-names></name></person-group>. <article-title>The role of G-protein-coupled receptor proteolysis site cleavage of polycystin-1 in renal physiology and polycystic kidney disease</article-title>. <source>Cells.</source>
<year>2016</year>;<volume>5</volume>(<issue>1</issue>):<fpage>3</fpage>. doi:<pub-id pub-id-type="doi">10.3390/cells5010003</pub-id><pub-id pub-id-type="pmid">26805887</pub-id>
</mixed-citation>
      </ref>
      <ref id="B41">
        <label>41.</label>
        <mixed-citation publication-type="book"><source>ADPKD Variant Database (PKDDB) [Internet]</source>. <comment>Accessed September 28, 2023. <ext-link xlink:href="http://pkdb.pkdcure.org" ext-link-type="uri">http://pkdb.pkdcure.org</ext-link></comment></mixed-citation>
      </ref>
      <ref id="B42">
        <label>42.</label>
        <mixed-citation publication-type="book"><source>ClinVar [Internet]</source>. <comment>Accessed September 28, 2023. <ext-link xlink:href="https://www.ncbi.nlm.nih.gov/clinvar/" ext-link-type="uri">https://www.ncbi.nlm.nih.gov/clinvar/</ext-link></comment></mixed-citation>
      </ref>
      <ref id="B43">
        <label>43.</label>
        <mixed-citation publication-type="book"><source>PKD [Internet]</source>. <comment>Accessed September 28, 2023. <ext-link xlink:href="https://pkdgenes.org/" ext-link-type="uri">https://pkdgenes.org/</ext-link></comment></mixed-citation>
      </ref>
      <ref id="B44">
        <label>44.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Irazabal</surname><given-names>MV</given-names></name>
<name><surname>Rangel</surname><given-names>LJ</given-names></name>
<name><surname>Bergstralh</surname><given-names>EJ</given-names></name>, <etal/></person-group>.; <collab>CRISP Investigators</collab>. <article-title>Imaging classification of autosomal dominant polycystic kidney disease: a simple model for selecting patients for clinical trials</article-title>. <source>J Am Soc Nephrol.</source>
<year>2015</year>;<volume>26</volume>(<issue>1</issue>):<fpage>160</fpage>&#x2013;<lpage>172</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2013101138</pub-id><pub-id pub-id-type="pmid">24904092</pub-id>
</mixed-citation>
      </ref>
      <ref id="B45">
        <label>45.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Grantham</surname><given-names>JJ</given-names></name>
<name><surname>Torres</surname><given-names>VE</given-names></name>
<name><surname>Chapman</surname><given-names>AB</given-names></name>, <etal/></person-group>.; <collab>CRISP Investigators</collab>. <article-title>Volume progression in polycystic kidney disease</article-title>. <source>N Engl J Med.</source>
<year>2006</year>;<volume>354</volume>(<issue>20</issue>):<fpage>2122</fpage>&#x2013;<lpage>2130</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa054341</pub-id><pub-id pub-id-type="pmid">16707749</pub-id>
</mixed-citation>
      </ref>
      <ref id="B46">
        <label>46.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Barua</surname><given-names>M</given-names></name>
<name><surname>Cil</surname><given-names>O</given-names></name>
<name><surname>Paterson</surname><given-names>AD</given-names></name>, <etal/></person-group>. <article-title>Family history of renal disease severity predicts the mutated gene in ADPKD</article-title>. <source>J Am Soc Nephrol.</source>
<year>2009</year>;<volume>20</volume>(<issue>8</issue>):<fpage>1833</fpage>&#x2013;<lpage>1838</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2009020162</pub-id><pub-id pub-id-type="pmid">19443633</pub-id>
</mixed-citation>
      </ref>
      <ref id="B47">
        <label>47.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Torres</surname><given-names>VE</given-names></name>
<name><surname>Abebe</surname><given-names>KZ</given-names></name>
<name><surname>Chapman</surname><given-names>AB</given-names></name>, <etal/></person-group>.; <collab>HALT-PKD Trial Investigators</collab>. <article-title>Angiotensin blockade in late autosomal dominant polycystic kidney disease</article-title>. <source>N Engl J Med.</source>
<year>2014</year>;<volume>371</volume>(<issue>24</issue>):<fpage>2267</fpage>&#x2013;<lpage>2276</lpage>. doi:<pub-id pub-id-type="doi">10.1056/NEJMoa1402686</pub-id><pub-id pub-id-type="pmid">25399731</pub-id>
</mixed-citation>
      </ref>
      <ref id="B48">
        <label>48.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornec-Le Gall</surname><given-names>E</given-names></name>
<name><surname>Audr&#xE9;zet</surname><given-names>M-P</given-names></name>
<name><surname>Rousseau</surname><given-names>A</given-names></name>, <etal/></person-group>. <article-title>The PROPKD score: a new algorithm to predict renal survival in autosomal dominant polycystic kidney disease</article-title>. <source>J Am Soc Nephrol.</source>
<year>2016</year>;<volume>27</volume>(<issue>3</issue>):<fpage>942</fpage>&#x2013;<lpage>951</lpage>. doi:<pub-id pub-id-type="doi">10.1681/ASN.2015010016</pub-id><pub-id pub-id-type="pmid">26150605</pub-id>
</mixed-citation>
      </ref>
      <ref id="B49">
        <label>49.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cornec-Le Gall</surname><given-names>E</given-names></name>
<name><surname>Blais</surname><given-names>JD</given-names></name>
<name><surname>Irazabal</surname><given-names>MV</given-names></name>, <etal/></person-group>. <article-title>Can we further enrich autosomal dominant polycystic kidney disease clinical trials for rapidly progressive patients? Application of the PROPKD score in the TEMPO trial</article-title>. <source>Nephrol Dial Transplant.</source>
<year>2018</year>;<volume>33</volume>(<issue>4</issue>):<fpage>645</fpage>&#x2013;<lpage>652</lpage>. doi:<pub-id pub-id-type="doi">10.1093/ndt/gfx188</pub-id><pub-id pub-id-type="pmid">28992127</pub-id>
</mixed-citation>
      </ref>
      <ref id="B50">
        <label>50.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Park</surname><given-names>HC</given-names></name>
<name><surname>Hong</surname><given-names>Y</given-names></name>
<name><surname>Yeon</surname><given-names>J-H</given-names></name>, <etal/></person-group>. <article-title>Mayo imaging classification is a good predictor of rapid progress among Korean patients with autosomal dominant polycystic kidney disease: results from the KNOW-CKD study</article-title>. <source>Kidney Res Clin Pract.</source>
<year>2022</year>;<volume>41</volume>(<issue>4</issue>):<fpage>432</fpage>&#x2013;<lpage>441</lpage>. doi:<pub-id pub-id-type="doi">10.23876/j.krcp.21.261</pub-id><pub-id pub-id-type="pmid">35286789</pub-id>
</mixed-citation>
      </ref>
      <ref id="B51">
        <label>51.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Higashihara</surname><given-names>E</given-names></name>
<name><surname>Nutahara</surname><given-names>K</given-names></name>
<name><surname>Itoh</surname><given-names>M</given-names></name>, <etal/></person-group>. <article-title>Long-term outcomes of longitudinal efficacy study with tolvaptan in ADPKD</article-title>. <source>Kidney Int Rep.</source>
<year>2022</year>;<volume>7</volume>(<issue>2</issue>):<fpage>270</fpage>&#x2013;<lpage>281</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ekir.2021.11.034</pub-id><pub-id pub-id-type="pmid">35155866</pub-id>
</mixed-citation>
      </ref>
      <ref id="B52">
        <label>52.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kataoka</surname><given-names>H</given-names></name>
<name><surname>Yoshida</surname><given-names>R</given-names></name>
<name><surname>Iwasa</surname><given-names>N</given-names></name>, <etal/></person-group>. <article-title>Germline mutations for kidney volume in ADPKD</article-title>. <source>Kidney Int Rep.</source>
<year>2022</year>;<volume>7</volume>(<issue>3</issue>):<fpage>537</fpage>&#x2013;<lpage>546</lpage>. doi:<pub-id pub-id-type="doi">10.1016/j.ekir.2021.12.012</pub-id><pub-id pub-id-type="pmid">35257066</pub-id>
</mixed-citation>
      </ref>
      <ref id="B53">
        <label>53.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kimura</surname><given-names>T</given-names></name>
<name><surname>Kawano</surname><given-names>H</given-names></name>
<name><surname>Muto</surname><given-names>S</given-names></name>, <etal/></person-group>. <article-title>PKD1 mutation is a biomarker for autosomal dominant polycystic kidney disease</article-title>. <source>Biomolecules.</source>
<year>2023</year>;<volume>13</volume>(<issue>7</issue>):<fpage>1020</fpage>. doi:<pub-id pub-id-type="doi">10.3390/biom13071020</pub-id><pub-id pub-id-type="pmid">37509056</pub-id>
</mixed-citation>
      </ref>
      <ref id="B54">
        <label>54.</label>
        <mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sch&#xF6;nauer</surname><given-names>R</given-names></name>
<name><surname>Sierks</surname><given-names>D</given-names></name>
<name><surname>Boerrigter</surname><given-names>M</given-names></name>, <etal/></person-group>.; <collab>Genomics England Research Consortium</collab>. <article-title>Sex, genotype, and liver volume progression as risk of hospitalization determinants in autosomal dominant polycystic liver disease</article-title>. <source>Gastroenterology.</source>
<year>2024</year>;<volume>166</volume>(<issue>5</issue>):<fpage>902</fpage>&#x2013;<lpage>914</lpage>. doi:<pub-id pub-id-type="doi">10.1053/j.gastro.2023.12.007</pub-id><pub-id pub-id-type="pmid">38101549</pub-id>
</mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>